Live Oak Bancshares (LOB) 10-Q 8 Aug 16 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2016	Aug. 05, 2016
Document Information [Line Items]
Entity Registrant Name	Live Oak Bancshares, Inc.
Entity Central Index Key	1,462,120
Trading Symbol	LOB
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Document Type	10-Q
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Voting Common Stock, Shares Outstanding
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		29,483,160
Entity Nonvoting Common Stock, Shares Outstanding
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		4,723,530

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015	[1]
Assets
Cash and due from banks	$ 175,506	$ 102,607
Certificates of deposit with other banks	8,500	10,250
Investment securities available-for-sale	66,804	53,762
Loans held for sale	329,206	480,619
Loans held for investment	690,517	279,969
Allowance for loan losses	(12,309)	(7,415)
Net loans	678,208	272,554
Premises and equipment, net	61,064	62,653
Foreclosed assets	2,971	2,666
Servicing assets	48,454	44,230
Other assets	24,591	23,281
Total assets	1,395,304	1,052,622
Deposits:
Noninterest-bearing	22,942	21,502
Interest-bearing	1,117,855	783,286
Total deposits	1,140,797	804,788
Long term borrowings	28,173	28,375
Other liabilities	18,984	19,971
Total liabilities	1,187,954	853,134
Shareholders’ equity
Retained earnings	15,928	12,140
Accumulated other comprehensive income (loss)	201	(192)
Total shareholders’ equity attributed to Live Oak Bancshares, Inc.	207,325	199,455
Noncontrolling interest	25	33
Total equity	207,350	199,488
Total liabilities and shareholders’ equity	1,395,304	1,052,622
Preferred Stock Undefined
Shareholders’ equity
Preferred stock, no par value, 1,000,000 authorized, none issued or outstanding at June 30, 2016 and December 31, 2015	0	0
Class A Common Stock
Shareholders’ equity
Common stock	141,181	137,492
Class B Common Stock
Shareholders’ equity
Common stock	$ 50,015	$ 50,015
[1]	Derived from audited consolidated financial statements.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - shares	Jun. 30, 2016	Dec. 31, 2015	[1]
Preferred Stock Undefined
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Common Stock
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	29,468,852	29,449,369
Common stock, shares outstanding	29,468,852	29,449,369
Class B Common Stock
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	4,723,530	4,723,530
Common stock, shares outstanding	4,723,530	4,723,530
[1]	Derived from audited consolidated financial statements.

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Interest income
Loans and fees on loans	$ 12,902	$ 7,408	$ 23,907	$ 14,138
Investment securities, taxable	252	200	503	376
Other interest earning assets	248	70	386	136
Total interest income	13,402	7,678	24,796	14,650
Interest expense
Deposits	3,243	1,801	5,687	3,277
Borrowings	242	444	483	885
Total interest expense	3,485	2,245	6,170	4,162
Net interest income	9,917	5,433	18,626	10,488
Provision for loan losses	3,453	50	4,886	1,127
Net interest income after provision for loan losses	6,464	5,383	13,740	9,361
Noninterest income
Loan servicing revenue	5,081	3,870	9,865	7,463
Loan servicing asset revaluation	(1,604)	(2,098)	(1,630)	(1,585)
Net gains on sales of loans	14,555	15,719	30,980	31,180
Equity in loss of non-consolidated affiliates	0	0	0	(26)
Gain on sale of investment in non-consolidated affiliate	0	0	0	3,782
Construction supervision fee income	667	317	1,297	533
Other noninterest income	649	327	1,268	843
Total noninterest income	19,348	18,135	41,780	42,190
Noninterest expense
Salaries and employee benefits	15,411	9,319	28,404	17,674
Travel expense	2,330	2,238	4,176	3,714
Professional services expense	910	548	1,438	1,398
Advertising and marketing expense	1,365	1,118	2,328	2,126
Occupancy expense	1,055	736	2,248	1,217
Data processing expense	1,404	722	2,612	1,615
Equipment expense	534	388	1,085	831
Other loan origination and maintenance expense	621	234	1,195	711
Other expense	1,502	1,514	3,357	2,233
Total noninterest expense	25,132	16,817	46,843	31,519
Income before taxes	680	6,701	8,677	20,032
Income tax expense	557	2,766	3,871	8,044
Net income	123	3,935	4,806	11,988
Net loss attributable to noncontrolling interest	0	0	8	20
Net income attributable to Live Oak Bancshares, Inc.	$ 123	$ 3,935	$ 4,814	$ 12,008
Basic earnings per share (in dollars per share)	$ 0	$ 0.14	$ 0.14	$ 0.42
Diluted earnings per share (in dollars per share)	$ 0	$ 0.13	$ 0.14	$ 0.41

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Statement of Comprehensive Income [Abstract]
Net income	$ 123	$ 3,935	$ 4,806	$ 11,988
Other comprehensive income (loss) before tax:
Net unrealized gain (loss) on investment securities arising during the period	251	(339)	640	(136)
Reclassification adjustment for (gain) loss on sale of securities available-for-sale included in net income	0	0	0	0
Other comprehensive income (loss) before tax	251	(339)	640	(136)
Income tax (expense) benefit	(97)	131	(247)	52
Other comprehensive income (loss), net of tax	154	(208)	393	(84)
Total comprehensive income	$ 277	$ 3,727	$ 5,199	$ 11,904

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total		Common stock	Common stockClass A Common Stock	Common stockClass B Common Stock	Retained earnings (accumulated deficit)	Accumulated other comprehensive income (loss)	Non- controlling interest
Beginning balance at Dec. 31, 2014	$ 91,814		$ 98,672			$ (6,943)	$ 85	$ 0
Beginning balance, shares at Dec. 31, 2014				23,896,400	4,723,530
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	11,988					12,008		(20)
Other comprehensive loss	(84)						(84)
Consolidation of investment with non-controlling interest	35							35
Stock option exercises	$ 154		154
Stock option exercise (shares)	34,930			34,930
Stock option based compensation expense	$ 295		295
Restricted stock expense	16		16
Capital contribution from non-controlling interest	22							22
Dividends (distributions to shareholders)	(859)					(859)
Ending balance at Jun. 30, 2015	103,381		99,137			4,206	1	37
Ending balance, shares at Jun. 30, 2015				23,931,330	4,723,530
Beginning balance at Dec. 31, 2015	199,488	[1]	187,507			12,140	(192)	33
Beginning balance, shares at Dec. 31, 2015				29,449,369	4,723,530
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	4,806					4,814		(8)
Other comprehensive loss	393						393
Issuance of restricted stock (shares)				2,776
Stock option exercises	$ 107		107
Stock option exercise (shares)	16,707			16,707
Stock option based compensation expense	$ 1,173		1,173
Restricted stock expense	2,409		2,409
Dividends (distributions to shareholders)	(1,026)					(1,026)
Ending balance at Jun. 30, 2016	$ 207,350		$ 191,196			$ 15,928	$ 201	$ 25
Ending balance, shares at Jun. 30, 2016				29,468,852	4,723,530
[1]	Derived from audited consolidated financial statements.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016		Jun. 30, 2015
Cash flows from operating activities
Net income	$ 4,806		$ 11,988
Adjustments to reconcile net income to net cash used by operating activities:
Depreciation and amortization	2,109		1,021
Provision for loan losses	4,886		1,127
Amortization of premium on securities, net of accretion	79		24
Amortization (accretion) of discount on unguaranteed loans, net	156		1,313
Deferred tax (benefit) expense	(1,457)		847
Originations of loans held for sale	(471,295)		(472,413)
Proceeds from sales of loans held for sale	322,748		318,125
Net gains on sale of loans held for sale	(30,980)		(31,180)
Net loss on sale of foreclosed assets	1		7
Net increase in servicing assets	(4,224)		(4,984)
Gain on sale of investment in non-consolidated affiliate	0		(3,782)
Net loss on disposal of premises and equipment	0		16
Stock option based compensation expense	1,173		295
Restricted stock expense	2,409		16
Equity in loss of non-consolidated affiliates	0		26
Changes in assets and liabilities:
Other assets	(1,301)		(3,192)
Other liabilities	478		2,402
Net cash used by operating activities	(170,412)		(178,344)
Cash flows from investing activities
Purchases of securities available-for-sale	(14,799)		(5,925)
Proceeds from sales, maturities, calls, and principal paydowns of securities available-for-sale	2,318		4,364
Proceeds from sale/collection of foreclosed assets	91		330
Maturities of certificates of deposit with other banks	1,750		0
Proceeds from sale of investment in non-consolidated affiliate	0		9,896
Net cash acquired in consolidation of equity method investment	0		319
Capital contribution from non-controlling interest	0		22
Loan originations and principal collections, net	(80,162)		84,252
Purchases of premises and equipment, net	(433)		(23,068)
Net cash (used in) provided by investing activities	(91,235)		70,190
Cash flows from financing activities
Net increase in deposits	336,009		205,266
Proceeds from long term borrowings	0		21,322
Repayment of long term borrowings	(202)		(8,681)
Repayment of short term borrowings	0		(6,100)
Stock option exercises	107		154
Shareholder dividend distributions	(1,368)		(2,222)
Net cash provided by financing activities	334,546		209,739
Net increase in cash and cash equivalents	72,899		101,585
Cash and cash equivalents, beginning	102,607	[1]	29,902
Cash and cash equivalents, ending	175,506		131,487
Supplemental disclosure of cash flow information
Interest paid	6,180		4,152
Income tax	2,776		9,174
Supplemental disclosures of noncash operating, investing, and financing activities
Unrealized holding gains (losses) on available-for-sale securities, net of taxes	393		(84)
Transfers from loans to foreclosed real estate and other repossessions	406		0
Transfers from foreclosed real estate to SBA receivable	9		0
Transfers of loans accounted for as secured borrowing collateral to other assets	0		4,575
Dividends declared but not paid	0		169
Transfer of loans held for sale to loans held for investment	336,263		7,400
Transfer of loans held for investment to loans held for sale	1,848		4,514
Contingent consideration in acquisition of controlling interest in equity method of investment	$ 0		$ 170
[1]	Derived from audited consolidated financial statements.

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Nature of Operations Live Oak Bancshares, Inc. (the “Company” or “LOB”) is a bank holding company headquartered in Wilmington, North Carolina incorporated under the laws of North Carolina in December 2008. The Company conducts business operations primarily through its commercial bank subsidiary, Live Oak Banking Company (the “Bank”). The Bank was established in May 2008 as a North Carolina-chartered commercial bank. The Bank specializes in providing lending services to small businesses nationwide in targeted industries. The Bank identifies and grows within credit-worthy industries through expertise within those industries. A significant portion of the loans originated by the Bank are guaranteed by the Small Business Administration (“SBA”) under the 7(a) program. On July 28, 2015 the Company completed its initial public offering. In 2010, the Bank formed Live Oak Number One, Inc., a wholly-owned subsidiary, to hold properties foreclosed on by the Bank. During 2011, the Company formed Independence Aviation, LLC, a wholly-owned subsidiary, for the purpose of purchasing and operating aircraft used for business purposes of the Company. The net assets of Independence Aviation, LLC were transferred to the Company and the Bank effective December 31, 2015 resulting in its dissolution. In addition to the Bank, the Company owns Live Oak Grove, LLC, opened in September 2015 for the purpose of providing Company employees and business visitors an on-site restaurant location, Government Loan Solutions, Inc. (“GLS”), a management and technology consulting firm that specializes in the settlement, accounting, and securitization processes for government guaranteed loans, including loans originated under the SBA 7(a) loan program and USDA-guaranteed loans, and 504 Fund Advisors, LLC (“504FA”), formed to serve as the investment adviser to the 504 Fund, a closed-end mutual fund organized to invest in SBA section 504 loans. The Company acquired control over 504FA, previously carried as an equity method investment, on February 2, 2015 by increasing its ownership from 50.0% to 91.3% . The acquisition of an additional 41.3% of ownership occurred in exchange for contingent consideration estimated to total $ 170 thousand . Transactions in the third quarter of 2015 and first quarter of 2016 increased the Company’s ownership to 92.9% . With 7.1% of ownership remaining with a third party investor, amounts of earnings and equity in 504FA attributable to the third party investor are now disclosed in the Company’s consolidated financial statements as related to a noncontrolling interest. The Company earns revenue primarily from the sale of SBA-guaranteed loans. This income is comprised of net gains on the sale of loans, revenues on the servicing of sold loans and valuation of loan servicing rights. Net interest income is another contributor to earnings. Offsetting these revenues are the cost of funding sources, provision for loan losses, any costs related to foreclosed assets and other operating costs such as salaries and employee benefits, travel, professional services, advertising and marketing and tax expense. General In the opinion of management, all adjustments necessary for a fair presentation of the financial position and results of operations for the periods presented have been included, and all intercompany transactions have been eliminated in consolidation. Results of operations for the six months ended June 30, 2016 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2016 . The consolidated balance sheet as of December 31, 2015 has been derived from the audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015 , filed with the Securities Exchange Commission on March 14, 2016 (SEC File No. 001-37497) (the "2015 Annual Report"). A summary description of the significant accounting policies followed by the Company is set forth in Note 1 of the Notes to Consolidated Financial Statements in the Company’s 2015 Annual Report. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes in the Company's 2015 Annual Report. The preparation of financial statements in conformity with United States generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. Amounts in all tables in the Notes to Unaudited Consolidated Financial Statements have been presented in thousands, except percentage, time period, stock option, share and per share data or where otherwise indicated. Business Segments Management has determined that the Company has one significant operating segment, which is providing a lending platform for small businesses nationwide. In determining the appropriateness of segment definition, the Company considers the materiality of a potential segment, the components of the business about which financial information is available, and components for which management regularly evaluates relative to resource allocation and performance assessment. Loans Reclassified to Held for Investment Loans receivable that management has the intent and ability to hold for the foreseeable future or until maturity or pay-off are classified as held for investment ("HFI") and reported at their outstanding principal amount adjusted for any charge-offs, the allowance for loan losses, and any deferred fees or costs on originated loans and unamortized premium or discount on purchased loans. Loan origination fees, net of certain direct origination costs, are deferred and recognized as an adjustment of the related loan yield using the interest method. Loans originated and intended for sale are classified as held for sale ("HFS") and carried at the lower of cost or estimated fair value. During the second quarter of 2016, the Bank transferred $318.8 million in unguaranteed loans from the HFS category to the HFI category to better reflect intentions of the Company. Allowance for Loan Losses The allowance for loan losses is established as losses are estimated to have occurred through a provision for loan losses charged to earnings. Loan losses are charged against the allowance when management believes the un-collectibility of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the allowance. The allowance for loan losses is evaluated on a regular basis by management and is based upon management’s periodic review of the collectibility of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as more information becomes available. Upon transfer from held for sale classification, loans held for investment become subject to the allowance for loan loss review process. As a result of this process, the above mentioned $318.8 million loan reclassification resulted in a $4.0 million increase in the provision for loan losses during the second quarter of 2016. During the second quarter of 2016, the Company also implemented enhancements to the methodology for estimating the allowance for loan losses, including refinements to the measurement of qualitative factors in the estimation process. Management believes these enhancements will improve the precision of the process for estimating the allowance, but did not fundamentally change the Company's approach. These revisions resulted in a $390 thousand reduction in the provision for loan losses during the second quarter of 2016. Reclassifications Certain reclassifications have been made to the prior period’s consolidated financial statements to place them on a comparable basis with the current year. Net income and shareholders’ equity previously reported were not affected by these reclassifications.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2016
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements In March 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-08, “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)” (“ASU 2016-08”). This guidance amends the previously issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2016-08 clarifies the implementation guidance on principal versus agent considerations in order to determine if revenue will be recognized on a gross or net basis. This guidance is effective for the Company on January 1, 2018 and is not expected to have a material impact on the consolidated financial statements. In March 2016, the FASB issued ASU No. 2016-09, “Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (“ASU 2016-09”). ASU 2016-09 simplifies the accounting for share-based payment transactions for items including income tax consequences, classification of awards as equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 will be effective for the Company on January 1, 2017 and the Company is currently assessing the impact the adoption of this standard will have on the consolidated financial statements. In April 2016, the FASB issued ASU No. 2016-10, "Identifying Performance Obligations and Licensing" ("ASU 2016-10"). This guidance amends the previously issued ASU No. 2014-09, "Revenue from Contracts with Customers (Topic 606)" ("ASU 2014-09"). ASU 2016-10 clarifies the guidance related to identifying performance obligations and accounting for licenses of intellectual property. The amendments will be effective for the Company on January 1, 2018. The Company does not expect these amendments to have a material effect on its consolidated financial statements. In May 2016, the FASB issued ASU 2016-12, "Narrow-Scope Improvements and Practical Expedients" ("ASU 2016-12"). This guidance also amends the previously issued ASU No. 2014-09 to clarify guidance related to collectibility, noncash consideration, presentation of sales tax and transition. The amendments will be effective for the Company on January 1, 2018. The Company does not expect these amendments to have a material effect on its consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, "Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13"). This new guidance replaces the incurred loss impairment methodology in current standards with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts and requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. ASU 2016-13 will be effective for the Company on January 1, 2020. The Company is currently evaluating the effect the implementation of the new standard will have on its consolidated financial statements.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2016
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic and diluted earnings per share are computed based on the weighted average number of shares outstanding during each period. Diluted earnings per share reflects the potential dilution that could occur, upon the exercise of stock options or upon the vesting of restricted stock grants, any of which would result in the issuance of common stock that would then be shared in the net income of the Company. Three Months Ended Six Months Ended 2016 2015 2016 2015 Basic earnings per share: Net income available to common shareholders $ 123 $ 3,935 $ 4,814 $ 12,008 Weighted-average basic shares outstanding 34,189,217 28,636,182 34,183,004 28,628,177 Basic earnings per share $ 0.00 $ 0.14 $ 0.14 $ 0.42 Diluted earnings per share: Net income available to common shareholders, for diluted earnings per share $ 123 $ 3,935 $ 4,814 $ 12,008 Total weighted-average basic shares outstanding 34,189,217 28,636,182 34,183,004 28,628,177 Add effect of dilutive stock options and restricted stock grants 1,016,908 862,217 896,656 811,645 Total weighted-average diluted shares outstanding 35,206,125 29,498,399 35,079,660 29,439,822 Diluted earnings per share $ 0.00 $ 0.13 $ 0.14 $ 0.41 Anti-dilutive shares 1,807,823 916,199 1,807,823 956,199

Securities

Securities	6 Months Ended
	Jun. 30, 2016
Investments, Debt and Equity Securities [Abstract]
Securities	Securities The carrying amount of securities and their approximate fair values are reflected in the following table: Amortized Cost Unrealized Gains Unrealized Losses Fair Value June 30, 2016 US government agencies $ 22,018 $ 165 $ — $ 22,183 Residential mortgage-backed securities 42,478 161 36 42,603 Mutual fund 1,981 37 — 2,018 Total $ 66,477 $ 363 $ 36 $ 66,804 December 31, 2015 US government agencies $ 21,992 $ 81 $ 5 $ 22,068 Residential mortgage-backed securities 30,131 1 374 29,758 Mutual fund 1,951 — 15 1,936 Total $ 54,074 $ 82 $ 394 $ 53,762 During the three months ended June 30, 2016 , the Company purchased four mortgage-backed securities for $ 12.3 million for the purpose of complying with the Community Reinvestment Act ("CRA"). In addition, during the first quarter of 2016, the Company purchased one mortgage-backed security for $ 2.4 million for the purchase of complying with the CRA. During the six months ended June 30, 2016 , there was $ 30 thousand of dividend reinvestment in the 504 Fund mutual fund. There were no calls, sales or maturities of securities during the three and six months ended June 30, 2016 . There were no calls or maturities of securities during the three and six months ended June 30, 2015 . During the three months ended June 30, 2015 , the Company sold six mortgage-backed securities at their carrying amount for $ 3.4 million in an odd-lot consolidation and purchased two mortgage-backed securities totaling $ 4.0 million for the purpose of complying with the Community Reinvestment Act. In addition, during the first quarter of 2015, the Company invested $ 1.9 million in the 504 Fund mutual fund. The investment in this mutual fund was purchased at current market value ( 190,380.762 shares at $ 9.98 per share). The following tables show gross unrealized losses and fair value, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position. Less Than 12 Months 12 Months or More Total June 30, 2016 Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Residential mortgage-backed securities $ 2,401 $ 16 $ 5,494 $ 20 $ 7,895 $ 36 Total $ 2,401 $ 16 $ 5,494 $ 20 $ 7,895 $ 36 Less Than 12 Months 12 Months or More Total December 31, 2015 Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses US government agencies $ 7,990 $ 5 $ — $ — $ 7,990 $ 5 Residential mortgage-backed securities 26,015 333 3,019 41 29,034 374 Mutual fund 1,936 15 — — 1,936 15 Total $ 35,941 $ 353 $ 3,019 $ 41 $ 38,960 $ 394 At June 30, 2016 , there were four mortgage-backed securities in unrealized loss positions for greater than 12 months and one mortgage-backed security in an unrealized loss position for less than 12 months. Unrealized losses at December 31, 2015 were comprised of three mortgage-backed securities in unrealized loss positions for greater than 12 months and one US government agency security, twelve mortgage-backed securities and the 504 Fund mutual fund investment in an unrealized loss position for less than 12 months. These unrealized losses are primarily the result of volatility in the market and are related to market interest rates. Since none of the unrealized losses relate to marketability of the securities or the issuer’s ability to honor redemption obligations, none of the securities are deemed to be other than temporarily impaired. All residential mortgage-backed securities in the Company’s portfolio at June 30, 2016 and December 31, 2015 were backed by US government sponsored enterprises (“GSEs”). The following is a summary of investment securities by maturity: June 30, 2016 Available-for-Sale Amortized cost Fair value US government agencies Within one year $ 9,210 $ 9,227 One to five years 12,808 12,956 Total 22,018 22,183 Residential mortgage-backed securities Five to ten years 8,324 8,402 After 10 years 34,154 34,201 Total 42,478 42,603 Total $ 64,496 $ 64,786 The table above reflects contractual maturities. Actual results will differ as the loans underlying the mortgage-backed securities may repay sooner than scheduled. This table excludes the 504 Fund mutual fund investment. At June 30, 2016 and December 31, 2015 , an investment security with a fair market value of $ 1.2 million and $ 1.3 million , respectively, was pledged to secure a line of credit with the Company’s correspondent bank. At June 30, 2016 , an investment security with a fair market value of $ 101 thousand was also pledged to the Ohio State Treasurer for the Company's trust department to conduct business in the state of Ohio.

Loans Held for Investment and A

Loans Held for Investment and Allowance for Loan Losses	6 Months Ended
	Jun. 30, 2016
Receivables [Abstract]
Loans Held for Investment and Allowance for Loan Losses	Loans Held for Investment and Allowance for Loan Losses Loan Portfolio Segments The following describes the risk characteristics relevant to each of the portfolio segments. Each loan category is assigned a risk grade during the origination and closing process based on criteria described later in this section. Commercial and Industrial Commercial and industrial loans (C&I) receive similar underwriting treatment as commercial real estate loans in that the repayment source is analyzed to determine its ability to meet cash flow coverage requirements as set forth by Bank policies. Repayment of the Bank’s C&I loans generally comes from the generation of cash flow as the result of the borrower’s business operations. This business cycle itself brings a certain level of risk to the portfolio. In some instances, these loans may carry a higher degree of risk due to a variety of reasons – illiquid collateral, specialized equipment, highly depreciable assets, uncollectable accounts receivable, revolving balances, or simply being unsecured. As a result of these characteristics, the SBA guarantee on these loans is an important factor in mitigating risk. Construction and Development Construction and development loans are for the purpose of acquisition and development of land to be improved through the construction of commercial buildings. Such loans are usually paid off through the conversion to permanent financing for the long-term benefit of the borrower’s ongoing operations. At the completion of the project, if the loan is converted to permanent financing or if scheduled loan amortization begins, it is then reclassified to the “Commercial Real Estate” segment. Underwriting of construction and development loans typically includes analysis of not only the borrower’s financial condition and ability to meet the required debt obligations, but also the general market conditions associated with the area and type of project being funded. Commercial Real Estate Commercial real estate loans are extensions of credit secured by owner occupied and non-owner occupied collateral. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies. Such repayment of commercial real estate loans is commonly derived from the successful ongoing operations of the business occupying the property. These typically include small businesses and professional practices. Commercial Land Commercial land loans are extensions of credit secured by farmland. Such loans are often for land improvements related to agricultural endeavors that may include construction of new specialized facilities. These loans are usually repaid through the conversion to permanent financing, or if scheduled loan amortization begins, for the long-term benefit of the borrower’s ongoing operations. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies. Each of the loan types referenced in the sections above is further segmented into verticals in which the Bank chooses to operate. The Bank chooses to finance businesses operating in specific industries because of certain similarities. The similarities range from historical default and loss characteristics to business operations. However, there are differences that create the necessity to underwrite these loans according to varying criteria and guidelines. When underwriting a loan, the Bank considers numerous factors such as cash flow coverage, the credit scores of the guarantors, revenue growth, practice ownership experience and debt service capacity. Minimum guidelines have been set with regard to these various factors and deviations from those guidelines require compensating strengths when considering a proposed loan. Loans consist of the following: June 30, December 31, Commercial & Industrial Agriculture $ 463 $ 30 Death Care Management 9,753 4,832 Healthcare 32,959 15,240 Independent Pharmacies 77,818 41,588 Registered Investment Advisors 54,091 18,358 Veterinary Industry 37,584 21,579 Other Industries 32,010 3,230 Total 244,678 104,857 Construction & Development Agriculture 35,041 11,351 Death Care Management 2,455 769 Healthcare 23,561 7,231 Independent Pharmacies 2,081 101 Registered Investment Advisors 703 378 Veterinary Industry 10,534 3,834 Other Industries 11,477 658 Total 85,852 24,322 Commercial Real Estate Agriculture 5,672 1,863 Death Care Management 45,162 20,327 Healthcare 95,146 37,684 Independent Pharmacies 13,650 7,298 Registered Investment Advisors 6,787 2,808 Veterinary Industry 96,162 59,999 Other Industries 23,739 4,752 Total 286,318 134,731 Commercial Land Agriculture 72,643 16,036 Total 72,643 16,036 Total Loans 1 689,491 279,946 Net Deferred Costs 6,902 3,056 Discount on SBA 7(a) Unguaranteed 2 (5,876 ) (3,033 ) Loans, Net of Unearned $ 690,517 $ 279,969 1 Total loans include $ 28.5 million and $ 17.2 million of U.S. government guaranteed loans as of June 30, 2016 and December 31, 2015 , respectively. 2 The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales. Credit Risk Profile The Bank uses internal loan reviews to assess the performance of individual loans by industry segment. An independent review of the loan portfolio is performed annually by an external firm. The goal of the Bank’s annual review of select borrowers' financial performance is to validate the adequacy of the risk grade assigned. The Bank uses a grading system to rank the quality of each loan. The grade is periodically evaluated and adjusted as performance dictates. Loan grades 1 through 4 are passing grades and grade 5 is special mention. Collectively, grades 6 through 8 represent classified loans in the Bank’s portfolio. The following guidelines govern the assignment of these risk grades: Exceptional Loans (1 Rated): These loans are of the highest quality, with strong, well-documented sources of repayment. Debt service coverage (“DSC”) is over 1.75 X based on historical results. Secondary source of repayment is strong, with a loan to value (“LTV”) of 65% or less if secured solely by commercial real estate (“CRE”). Discounted collateral coverage from all sources should exceed 125% . Guarantors have credit scores above 740 . Quality Loans (2 Rated): These loans are of good quality, with good, well-documented sources of repayment. DSC is over 1.25 X based on historical or pro-forma results. Secondary source of repayment is good, with a LTV of 75% or less if secured solely by CRE. Discounted collateral coverage should exceed 100% . Guarantors have credit scores above 700 . Acceptable Loans (3 rated): These loans are of acceptable quality, with acceptable sources of repayment. DSC of over 1.00 X based on historical or pro-forma results. Companies that do not meet these credit metrics must be evaluated to determine if they should be graded below this level. Acceptable Loans (4 rated): These loans are considered very weak pass. These loans are riskier than a 3-rated credit, but due to various mitigating factors are not considered a Special mention or worse. The mitigating factors must clearly be identified to offset further downgrade. Examples of loans that may be put in this category include start-up loans and loans with less than 1 :1 cash flow coverage with other sources of repayment. Special mention (5 rated): These loans are considered as emerging problems, with potentially unsatisfactory characteristics. These loans require greater management attention. A loan may be put into this category if the Bank is unable to obtain financial reporting from a company to fully evaluate its position. Substandard (6 rated): Loans graded Substandard are inadequately protected by current sound net worth, paying capacity of the borrower, or pledged collateral. They typically have unsatisfactory characteristics causing more than acceptable levels of risk, and have one or more well-defined weaknesses that could jeopardize the repayment of the debt. Doubtful (7 rated): Loans graded Doubtful have inherent weaknesses that make collection or liquidation in full questionable. Loans graded Doubtful must be placed on non-accrual status. Loss (8 rated): Loss rated loans are considered uncollectible and of such little value that their continuance as an active Bank asset is not warranted. The asset should be charged off, even though partial recovery may be possible in the future. The following tables summarize the risk grades of each category: Risk Grades 1 - 4 Risk Grade 5 Risk Grades 6 - 8 Total June 30, 2016 Commercial & Industrial Agriculture $ 406 $ 57 $ — $ 463 Death Care Management 9,518 226 9 9,753 Healthcare 25,201 3,362 4,396 32,959 Independent Pharmacies 72,619 3,620 1,579 77,818 Registered Investment Advisors 52,617 1,101 373 54,091 Veterinary Industry 33,504 1,883 2,197 37,584 Other Industries 32,010 — — 32,010 Total 225,875 10,249 8,554 244,678 Construction & Development Agriculture 35,041 — — 35,041 Death Care Management 2,049 406 — 2,455 Healthcare 21,340 2,221 — 23,561 Independent Pharmacies 2,081 — — 2,081 Registered Investment Advisors 703 — — 703 Veterinary Industry 9,341 1,193 — 10,534 Other Industries 11,477 — — 11,477 Total 82,032 3,820 — 85,852 Commercial Real Estate Agriculture 5,672 — — 5,672 Death Care Management 41,173 2,405 1,584 45,162 Healthcare 88,389 5,724 1,033 95,146 Independent Pharmacies 12,053 1,597 — 13,650 Registered Investment Advisors 6,787 — — 6,787 Veterinary Industry 81,384 4,096 10,682 96,162 Other Industries 23,739 — — 23,739 Total 259,197 13,822 13,299 286,318 Commercial Land Agriculture 70,636 1,890 117 72,643 Total 70,636 1,890 117 72,643 Total 1 $ 637,740 $ 29,781 $ 21,970 $ 689,491 Risk Grades 1 - 4 Risk Grade 5 Risk Grades 6 - 8 Total December 31, 2015 Commercial & Industrial Agriculture $ 30 $ — $ — $ 30 Death Care Management 4,728 104 — 4,832 Healthcare 8,334 2,160 4,746 15,240 Independent Pharmacies 36,704 3,430 1,454 41,588 Registered Investment Advisors 17,508 850 — 18,358 Veterinary Industry 16,800 1,817 2,962 21,579 Other Industries 3,089 141 — 3,230 Total 87,193 8,502 9,162 104,857 Construction & Development Agriculture 11,194 157 — 11,351 Death Care Management 769 — — 769 Healthcare 7,231 — — 7,231 Independent Pharmacies 101 — — 101 Registered Investment Advisors 378 — — 378 Veterinary Industry 2,581 1,253 — 3,834 Other Industries 658 — — 658 Total 22,912 1,410 — 24,322 Commercial Real Estate Agriculture 1,863 — — 1,863 Death Care Management 18,223 425 1,679 20,327 Healthcare 33,529 2,930 1,225 37,684 Independent Pharmacies 6,210 1,088 — 7,298 Registered Investment Advisors 2,808 — — 2,808 Veterinary Industry 45,453 3,171 11,375 59,999 Other Industries 4,752 — — 4,752 Total 112,838 7,614 14,279 134,731 Commercial Land Agriculture 16,036 — — 16,036 Total 16,036 — — 16,036 Total 1 $ 238,979 $ 17,526 $ 23,441 $ 279,946 1 Total loans include $ 28.5 million of U.S. government guaranteed loans as of June 30, 2016 , segregated by risk grade as follows: Risk Grades 1 – 4 = $ 7.7 million, Risk Grade 5 = $ 7.6 million , Risk Grades 6 – 8 = $ 13.2 million . As of December 31, 2015 , total loans include $ 17.2 million of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $ 0 , Risk Grade 5 = $ 2.6 million , Risk Grades 6 – 8 = $ 14.6 million . Past Due Loans Loans are considered past due if the required principal and interest payments have not been received as of the date such payments were due. Loans less than 30 days past due and accruing are included within current loans shown below. The following tables show an age analysis of past due loans as of the dates presented. Less Than 30 Days Past Due & Not Accruing 30-89 Days Past Due & Accruing 30-89 Days Past Due & Not Accruing Greater Than 90 Days Past Due Total Not Accruing & Past Due Loans Current Loans Total Loans Loans 90 Days or More Past Due & Still Accruing June 30, 2016 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 463 $ 463 $ — Death Care Management — — — — — 9,753 9,753 — Healthcare — 576 487 2,219 3,282 29,677 32,959 — Independent Pharmacies 294 415 156 270 1,135 76,683 77,818 — Registered Investment Advisors — — — — — 54,091 54,091 — Veterinary Industry 90 — 690 1,054 1,834 35,750 37,584 — Other Industries — — — — — 32,010 32,010 — Total 384 991 1,333 3,543 6,251 238,427 244,678 — Construction & Development Agriculture — — — — — 35,041 35,041 — Death Care Management — — — — — 2,455 2,455 — Healthcare — — — — — 23,561 23,561 — Independent Pharmacies — — — — — 2,081 2,081 — Registered Investment Advisors — — — — — 703 703 — Veterinary Industry — — — — — 10,534 10,534 — Other Industries — — — — — 11,477 11,477 — Total — — — — — 85,852 85,852 — Commercial Real Estate Agriculture — — — — — 5,672 5,672 — Death Care Management — 221 — 1,423 1,644 43,518 45,162 — Healthcare 350 258 — 209 817 94,329 95,146 — Independent Pharmacies — — — — — 13,650 13,650 — Registered Investment Advisors — — — — — 6,787 6,787 — Veterinary Industry 2,224 4,284 — 3,319 9,827 86,335 96,162 — Other Industries — — — — — 23,739 23,739 — Total 2,574 4,763 — 4,951 12,288 274,030 286,318 — Commercial Land Agriculture 117 — — — 117 72,526 72,643 — Total 117 — — — 117 72,526 72,643 — Total 1 $ 3,075 $ 5,754 $ 1,333 $ 8,494 $ 18,656 $ 670,835 $ 689,491 $ — Less Than 30 Days Past Due & Not Accruing 30-89 Days Past Due & Accruing 30-89 Days Past Due & Not Accruing Greater Than 90 Days Past Due Total Not Accruing & Past Due Loans Current Loans Total Loans Loans 90 Days or More Past Due & Still Accruing December 31, 2015 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 30 $ 30 $ — Death Care Management — — — — — 4,832 4,832 — Healthcare — 1,854 30 2,337 4,221 11,019 15,240 — Independent Pharmacies 314 603 — — 917 40,671 41,588 — Registered Investment Advisors — — — — — 18,358 18,358 — Veterinary Industry 208 466 1,131 394 2,199 19,380 21,579 — Other Industries — — — — — 3,230 3,230 — Total 522 2,923 1,161 2,731 7,337 97,520 104,857 — Construction & Development Agriculture — — — — — 11,351 11,351 — Death Care Management — — — — — 769 769 — Healthcare — — — — — 7,231 7,231 — Independent Pharmacies — — — — — 101 101 — Registered Investment Advisors — — — — — 378 378 — Veterinary Industry — — — — — 3,834 3,834 — Other Industries — — — — — 658 658 — Total — — — — — 24,322 24,322 — Commercial Real Estate Agriculture — — — — — 1,863 1,863 — Death Care Management 1,456 223 — — 1,679 18,648 20,327 — Healthcare — 240 135 831 1,206 36,478 37,684 — Independent Pharmacies — — — — — 7,298 7,298 — Registered Investment Advisors — — — — — 2,808 2,808 — Veterinary Industry 311 5,079 2,048 3,172 10,610 49,389 59,999 — Other Industries — — — — — 4,752 4,752 — Total 1,767 5,542 2,183 4,003 13,495 121,236 134,731 — Commercial Land Agriculture — — — — — 16,036 16,036 — Total — — — — — 16,036 16,036 — Total 1 $ 2,289 $ 8,465 $ 3,344 $ 6,734 $ 20,832 $ 259,114 $ 279,946 $ — 1 Total loans include $ 28.5 million of U.S. government guaranteed loans as of June 30, 2016 , of which $ 7.4 million is greater than 90 days past due, $ 3.5 million is 30-89 days past due and $ 17.6 million is included in current loans as presented above. As of December 31, 2015 , total loans include $ 17.2 million of U.S. government guaranteed loans, of which $ 5.9 million is greater than 90 days past due, $ 6.7 million is 30-89 days past due and $ 4.6 million is included in current loans as presented above. Nonaccrual Loans Loans that become 90 days delinquent, or in cases where there is evidence that the borrower’s ability to make the required payments is impaired, are placed in nonaccrual status and interest accrual is discontinued. If interest on nonaccrual loans had been accrued in accordance with the original terms, interest income would have increased by approximately $ 162 thousand and $ 102 thousand for the three months ended June 30, 2016 and 2015 , respectively and for the six months ended June 30, 2016 and 2015 interest income would have increased approximately $ 301 thousand and $ 261 thousand , respectively. All nonaccrual loans are included in the held for investment portfolio. Nonaccrual loans as of June 30, 2016 and December 31, 2015 are as follows: June 30, 2016 Loan Balance Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 2,706 $ 2,463 $ 243 Independent Pharmacies 720 558 162 Veterinary Industry 1,834 1,688 146 Total 5,260 4,709 551 Commercial Real Estate Death Care Management 1,423 1,264 159 Healthcare 559 306 253 Veterinary Industry 5,543 4,332 1,211 Total 7,525 5,902 1,623 Commercial Land Agriculture 117 117 — Total 117 117 — Total $ 12,902 $ 10,728 $ 2,174 December 31, 2015 Loan Balance Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 2,367 $ 2,188 $ 179 Independent Pharmacies 314 308 6 Veterinary Industry 1,733 1,572 161 Total 4,414 4,068 346 Commercial Real Estate Death Care Management 1,456 1,290 166 Healthcare 966 798 168 Veterinary Industry 5,531 4,174 1,357 Total 7,953 6,262 1,691 Total $ 12,367 $ 10,330 $ 2,037 Allowance for Loan Loss Methodology The methodology and the estimation process for calculating the Allowance for Loan Losses (“ALL”) is described below: Estimated credit losses should meet the criteria for accrual of a loss contingency, i.e., a provision to the ALL, set forth in GAAP. The Company’s methodology for determining the ALL is based on the requirements of GAAP, the Interagency Policy Statement on the Allowance for Loan and Lease Losses and other regulatory and accounting pronouncements. The ALL is determined by the sum of three separate components: (i) the impaired loan component, which addresses specific reserves for impaired loans; (ii) the general reserve component, which addresses reserves for pools of homogeneous loans; and (iii) an unallocated reserve component (if any) based on management’s judgment and experience. The loan pools and impaired loans are mutually exclusive; any loan that is impaired is excluded from its homogenous pool for purposes of that pool’s reserve calculation, regardless of the level of impairment. The ALL policy for pooled loans is governed in accordance with banking regulatory guidance for homogenous pools of non-impaired loans that have similar risk characteristics. The Company follows a consistent and structured approach for assessing the need for reserves within each individual loan pool. Loans are considered impaired when, based on current information and events, it is probable that the creditor will be unable to collect all interest and principal payments due according to the originally contracted, or reasonably modified, terms of the loan agreement. The Company has determined that loans that meet the criteria defined below must be reviewed quarterly to determine if they are impaired. • All commercial loans classified substandard or worse. • Any other delinquent loan that is in a nonaccrual status, or any loan that is delinquent more than 89 days and still accruing interest. • Any loan which has been modified such that it meets the definition of a Troubled Debt Restructuring (TDR). Prior to December 31, 2015, all loans subject to impairment recognition were individually evaluated for impairment. Effective December 31, 2015, the Company’s policy for impaired loan accounting subjects all loans to impairment recognition; however, loan relationships with unguaranteed credit exposure of less than $100,000 are generally not evaluated on an individual basis for impairment and instead are evaluated collectively using a methodology based on historical specific reserves on similar sized loans. Any loan not meeting the above criteria and determined to be impaired is subjected to an impairment analysis, which is a calculation of the probable loss on the loan. This portion is the loan’s “impairment,” and is established as a specific reserve against the loan, or charged against the ALL. This revision to the allowance methodology did not have a material impact on the allowance recorded at December 31, 2015. Individual specific reserve amounts imply probability of loss and may not be carried in the reserve indefinitely. When the amount of the actual loss becomes reasonably quantifiable, the amount of the loss is charged off against the ALL, whether or not all liquidation and recovery efforts have been completed. If the total amount of the individual specific reserve that will eventually be charged off cannot yet be sufficiently quantified but some portion of the impairment can be viewed as a confirmed loss, then the confirmed loss portion should be charged off against the ALL and the individual specific reserve reduced by a corresponding amount. For impaired loans, the reserve amount is calculated on a loan-specific basis. The Company utilizes two methods of analyzing impaired loans not guaranteed by the SBA: • The Fair Market Value of Collateral method utilizes the value at which the collateral could be sold considering the appraised value, appraisal discount rate, prior liens and selling costs. The amount of the reserve is the deficit of the estimated collateral value compared to the loan balance. • The Present Value of Future Cash Flows method takes into account the amount and timing of cash flows and the effective interest rate used to discount the cash flows. The following table details activity in the allowance for loan losses by portfolio segment allowance for the periods presented: Three months ended: Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total June 30, 2016 Beginning Balance $ 1,163 $ 2,575 $ 3,345 $ 1,533 $ 8,616 Charge offs — — (100 ) (63 ) (163 ) Recoveries — 3 400 — 403 Provision 45 1,501 1,956 (49 ) 3,453 Ending Balance $ 1,208 $ 4,079 $ 5,601 $ 1,421 $ 12,309 June 30, 2015 Beginning Balance $ 755 $ 2,062 $ 2,063 $ 354 $ 5,234 Charge offs — (42 ) (186 ) — (228 ) Recoveries — 87 40 — 127 Provision 89 239 (264 ) (14 ) 50 Ending Balance $ 844 $ 2,346 $ 1,653 $ 340 $ 5,183 Six months ended: Construction & Commercial Commercial Commercial Total June 30, 2016 Beginning Balance $ 1,064 $ 2,486 $ 2,766 $ 1,099 $ 7,415 Charge offs — (7 ) (368 ) (63 ) (438 ) Recoveries — 3 443 — 446 Provision 144 1,597 2,760 385 4,886 Ending Balance $ 1,208 $ 4,079 $ 5,601 $ 1,421 $ 12,309 June 30, 2015 Beginning Balance $ 586 $ 2,291 $ 1,369 $ 161 $ 4,407 Charge offs — (121 ) (358 ) — (479 ) Recoveries — 88 40 — 128 Provision 258 88 602 179 1,127 Ending Balance $ 844 $ 2,346 $ 1,653 $ 340 $ 5,183 The following tables detail the recorded allowance for loan losses and the investment in loans related to each portfolio segment, disaggregated on the basis of impairment evaluation methodology: June 30, 2016 Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total Allowance for Loan Losses: Loans individually evaluated for impairment $ — $ 874 $ 996 $ — $ 1,870 Loans collectively evaluated for impairment 2 1,208 3,205 4,605 1,421 10,439 Total allowance for loan losses $ 1,208 $ 4,079 $ 5,601 $ 1,421 $ 12,309 Loans receivable 1 : Loans individually evaluated for impairment $ — $ 11,536 $ 3,320 $ — $ 14,856 Loans collectively evaluated for impairment 2 85,852 274,782 241,358 72,643 674,635 Total loans receivable $ 85,852 $ 286,318 $ 244,678 $ 72,643 $ 689,491 December 31, 2015 Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total Allowance for Loan Losses: Loans individually evaluated for impairment $ — $ 1,090 $ 672 $ — $ 1,762 Loans collectively evaluated for impairment 2 1,064 1,396 2,094 1,099 5,653 Total allowance for loan losses $ 1,064 $ 2,486 $ 2,766 $ 1,099 $ 7,415 Loans receivable 1 : Loans individually evaluated for impairment $ — $ 9,821 $ 3,226 $ — $ 13,047 Loans collectively evaluated for impairment 2 24,322 124,910 101,631 16,036 266,899 Total loans receivable $ 24,322 $ 134,731 $ 104,857 $ 16,036 $ 279,946 1 Loans receivable includes $ 28.5 million of U.S. government guaranteed loans as of June 30, 2016 , of which $ 13.3 million are impaired. As of December 31, 2015 , loans receivable includes $ 17.2 million of U.S. government guaranteed loans, of which $ 14.1 million are considered impaired. 2 Included in loans collectively evaluated for impairment are impaired loans with individual unguaranteed exposure of less than $100 thousand. As of June 30, 2016 , these balances totaled $ 9.3 million , of which $ 7.4 million are guaranteed by the U.S. government and $ 1.9 million are unguaranteed. As of December 31, 2015 , these balances totaled $ 8.6 million , of which $ 7.5 million are guaranteed by the U.S. government and $ 1.1 million are unguaranteed. The allowance for loan losses associated with these loans totaled $ 589 thousand and $ 352 thousand as of June 30, 2016 and December 31, 2015 , respectively. Loans classified as impaired as of the dates presented are summarized in the following tables. June 30, 2016 Recorded Investment Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Death Care Management $ 9 $ — $ 9 Healthcare 4,405 2,463 1,942 Independent Pharmacies 1,918 870 1,048 Registered Investment Advisors 376 — 376 Veterinary Industry 2,553 1,829 724 Total 9,261 5,162 4,099 Commercial Real Estate Death Care Management 1,582 1,264 318 Healthcare 1,032 306 726 Veterinary Industry 12,130 6,480 5,650 Total 14,744 8,050 6,694 Commercial Land Agriculture 117 117 — Total 117 117 — Total $ 24,122 $ 13,329 $ 10,793 December 31, 2015 Recorded Investment Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 4,442 $ 3,341 $ 1,101 Independent Pharmacies 1,546 637 909 Veterinary Industry 2,256 1,731 525 Total 8,244 5,709 2,535 Commercial Real Estate Death Care Management 1,454 1,290 164 Healthcare 965 799 166 Veterinary Industry 11,003 6,349 4,654 Total 13,422 8,438 4,984 Total $ 21,666 $ 14,147 $ 7,519 The following table presents evaluated balances of loans classified as impaired at the dates presented that carried an associated reserve as compared to those with no reserve. The recorded investment includes accrued interest and net deferred loan fees or costs. June 30, 2016 Recorded Investment With a Recorded Allowance With No Recorded Allowance Total Unpaid Principal Balance Related Allowance Recorded Commercial & Industrial Death Care Management $ 9 $ — $ 9 $ 9 $ 3 Healthcare 4,139 266 4,405 4,461 671 Independent Pharmacies 1,737 181 1,918 2,012 338 Registered Investment Advisors 376 — 376 373 44 Veterinary Industry 2,553 — 2,553 2,934 285 Total 8,814 447 9,261 9,789 1,341 Commercial Real Estate Death Care Management 1,582 — 1,582 1,718 54 Healthcare 903 129 1,032 1,033 142 Veterinary Industry 9,319 2,811 12,130 12,886 921 Total 11,804 2,940 14,744 15,637 1,117 Commercial Land Agriculture 117 — 117 180 1 Total 117 — 117 180 1 Total Impaired Loans $ 20,735 $ 3,387 $ 24,122 $ 25,606 $ 2,459 December 31, 2015 Recorded Investment With a Recorded Allowance With No Recorded Allowance Total Unpaid Principal Balance Related Allowance Recorded Commercial & Industrial Healthcare $ 4,242 $ 200 $ 4,442 $ 4,742 $ 478 Independent Pharmacies 1,199 347 1,546 2,041 287 Veterinary Industry 2,051 205 2,256 3,270 138 Total 7,492 752 8,244 10,053 903 Commercial Real Estate Death Care Management 1,454 — 1,454 1,591 9 Healthcare 965 — 965 1,096 96 Veterinary Industry 9,265 1,738 11,003 11,856 1,106 Total 11,684 1,738 13,422 14,543 1,211 Total Impaired Loans $ 19,176 $ 2,490 $ 21,666 $ 24,596 $ 2,114 Three months ended Three months ended Average Interest Average Interest Commercial & Industrial Death Care Management $ 9 $ — $ — $ — Healthcare 4,440 21 3,320 25 Independent Pharmacies 1,935 17 3,751 13 Registered Investment Advisors 379 5 — — Veterinary Industry 2,640 9 2,864 5 Total 9,403 52 9,935 43 Commercial Real Estate Death Care Management 1,582 2 1,418 — Healthcare 1,038 7 2,502 — Veterinary Industry 12,189 84 13,530 51 Total 14,809 93 17,450 51 Commercial Land Agriculture 335 — — — Total 335 — — — Total $ 24,547 $ 145 $ 27,385 $ 94 Six months ended Six months ended Average Interest Average Interest Commercial & Industrial Death Care Management $ 9 $ — $ — $ — Healthcare 4,721 32 3,534 48 Independent Pharmacies 1,907 33 2,784 25 Registered Investment Advisors 381 7 — — Veterinary Industry 2,675 16 3,334 8 Total 9,693 88 9,652 81 Commercial Real Estate Death Care Management 1,588 3 1,475 — Healthcare 1,055 9 2,319 — Veterinary Industry 12,319 159 12,668 90 Total 14,962 171 16,462 90 Commercial Land Agriculture 429 — — — Total 429 — — — Total $ 25,084 $ 259 $ 26,114 $ 171 There were no new TDRs made during the three months ended June 30, 2016 and 2015 . The following table present the types of TDRs that were made during the six months ended June 30, 2016 and 2015 : Six months ended June 30, 2016 Six months ended June 30, 2015 All Restructurings All Restructurings Number of Pre- Post- Number of Pre- Post- Interest Only Commercial & Industrial Healthcare — $ — $ — 3 $ 229 $ 133 Commercial Real Estate Healthcare — — — 1 41 24 Total Interest Only — — — 4 270 157 Payment Deferral Commercial & Industrial Veterinary Industry 1 420 420 — — — Total Payment Deferral 1 420 420 — — — Total 1 $ 420 $ 420 4 $ 270 $ 157 Concessions made to improve a loan’s performance have varying degrees of success. The following table presents loans that were modified as TDRs within the previous twelve months ending June 30, 2016 and 2015 for which there was a payment default: June 30, 2016 June 30, 2015 TDR Defaults TDR Defaults Number of Restructurings Recorded Investment Number of Restructurings Recorded Investment Interest Only Commercial & Industrial Healthcare — $ — 3 $ 133 Independent Pharmacies — — 1 139 Commercial Real Estate Healthcare — — 1 24 Veterinary Industry — — 1 — Total Interest Only — — 6 296 Payment Deferral Commercial & Industrial Veterinary Industry 1 313 — — Commercial Real Estate Deathcare Management — — 1 1,675 Total Payment Deferral 1 313 1 1,675 Total 1 $ 313 7 $ 1,971

Servicing Assets

Servicing Assets	6 Months Ended
	Jun. 30, 2016
Transfers and Servicing [Abstract]
Servicing Assets	Servicing Assets Loans serviced for others are not included in the accompanying balance sheet. The unpaid principal balances of loans serviced for others were $ 2.12 billion and $ 1.94 billion at June 30, 2016 and December 31, 2015 , respectively. The following summarizes the activity pertaining to servicing rights: Three Months Ended Six Months Ended 2016 2015 2016 2015 Balance at beginning of period $ 47,377 $ 38,457 $ 44,230 $ 34,999 Additions, net 3,243 3,373 6,958 6,709 Fair value changes: Due to changes in valuation inputs or assumptions (262 ) (955 ) $ 559 $ 451 Decay due to increases in principal paydowns or runoff (1,904 ) (892 ) $ (3,293 ) $ (2,176 ) Balance at end of period $ 48,454 $ 39,983 $ 48,454 $ 39,983 The fair value of servicing rights was determined using discount rates ranging from 7.6% to 13.1% on June 30, 2016 , and 7.1% to 12.4% on June 30, 2015 . The fair value of servicing rights was determined using prepayment speeds ranging from 3.4% to 10.1% on June 30, 2016 and 4.2% to 9.6% on June 30, 2015 , depending on the stratification of the specific right. Changes to fair value are reported in loan servicing asset revaluation within the consolidated statements of income. The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Changes in prepayment speed assumptions have the most significant impact on the fair value of servicing rights. Generally, as interest rates rise on variable rate loans, loan prepayments increase due to an increase in refinance activity, which results in a decrease in the fair value of servicing assets. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time, and those assumptions may not be appropriate if they are applied at a different time.

Borrowings

Borrowings	6 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
Borrowings	Borrowings Total outstanding long term borrowings consisted of the following: June 30, December 31, Long term borrowings On September 11, 2014, the Company financed the construction of an additional building located on the Company’s Tiburon Drive main campus with a $24 million construction line of credit with an unaffiliated commercial bank, secured by both properties at its Tiburon Drive main facility location. Payments are interest only through September 11, 2016 at a fixed rate of 3.95% for a term of 84 months. Monthly principal and interest payments beginning in October 2016 will be $146 thousand with all principal and accrued interest due on September 11, 2021. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. The construction line is fully disbursed and there was no remaining available credit on this construction line at June 30, 2016. $ 23,995 $ 24,000 On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank, with the first advance of $5 million on December 14, 2014. The note is unsecured and accrues interest at LIBOR plus 3.50% for a term of 36 months. Payments are interest only with all principal and accrued interest due on September 18, 2017. This line of credit was paid in full on July 30, 2015 and there is $8.1 million of available credit remaining at June 30, 2016. — — On February 23, 2015, the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at June 30, 2016 is 4.50%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $4.2 million at June 30, 2016. Underlying loans carry a risk grade of 3 and are current with no delinquencies. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. 4,178 4,375 Total long term borrowings $ 28,173 $ 28,375 The Company may purchase federal funds though secured and unsecured federal funds lines of credit with various correspondent banks, which totaled $26.5 million as of June 30, 2016 and December 31, 2015 . These lines are intended for short-term borrowings and are subject to restrictions limiting the frequency and terms of advances. These lines of credit are payable on demand and bear interest based upon the daily federal funds rate. The Company had no outstanding balances on the lines of credit as of June 30, 2016 and December 31, 2015 . The Company has entered into a repurchase agreement with a third party for $5 million as of June 30, 2016 and December 31, 2015 . At the time the Company enters into a transaction with the third party, the Company must transfer securities or other assets against the funds received. The terms of the agreement are set at market conditions at the time the Company enters into such transaction. The Company had no outstanding balance on the repurchase agreement as of June 30, 2016 and December 31, 2015 . The Company may borrow funds through the Federal Reserve Bank’s discount window. These borrowings are secured by a blanket floating lien on qualifying loans with a balance of $228.8 million and $192.2 million as of June 30, 2016 and December 31, 2015 , respectively. At June 30, 2016 and December 31, 2015 , the Company had approximately $111.5 million and $86.7 million , respectively, in borrowing capacity available under these arrangements with no outstanding balance as of June 30, 2016 and December 31, 2015 .

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2016
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value Hierarchy There are three levels of inputs in the fair value hierarchy that may be used to measure fair value. Financial instruments are considered Level 1 when valuation can be based on quoted prices in active markets for identical assets or liabilities. Level 2 financial instruments are valued using quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or models using inputs that are observable or can be corroborated by observable market data of substantially the full term of the assets or liabilities. Financial instruments are considered Level 3 when their values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable and when determination of the fair value requires significant management judgment or estimation. Financial Instruments Measured at Fair Value The following sections provide a description of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the fair value hierarchy: Investment Securities: Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities would include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, discounted cash flow or at net asset value per share. Level 2 securities would include US government agency securities, mortgage-backed securities, obligations of states and political subdivisions and certain corporate, asset backed mutual fund and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy. Impaired Loans : Impairment of a loan is based on the fair value of the collateral of the loan for collateral-dependent loans. Fair value of the loan’s collateral, when the loan is dependent on collateral, is determined by appraisals or independent valuation which is then adjusted for the cost related to liquidation of the collateral. For non-collateral dependent loans, impairment is determined by the present value of expected future cash flows. Impaired loans classified as Level 3 are based on management’s judgment and estimation. Servicing Assets: Servicing rights do not trade in an active, open market with readily observable prices. While sales of servicing rights do occur, the precise terms and conditions typically are not readily available. Accordingly, the Company estimates the fair value of servicing rights using discounted cash flow models incorporating numerous assumptions from the perspective of a market participant including servicing income, servicing costs, market discount rates and prepayment speeds. Due to the nature of the valuation inputs, servicing rights are classified within Level 3 of the valuation hierarchy. Foreclosed Assets: Foreclosed real estate is adjusted to fair value less selling costs upon transfer of the loans to foreclosed real estate. Subsequently, foreclosed real estate is carried at the lower of carrying value or fair value less selling costs. Fair value is based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral. Given the lack of observable market prices for identical properties and market discounts applied to appraised values, the Company generally classifies foreclosed assets as nonrecurring Level 3. Recurring Fair Value The tables below present the recorded amount of assets and liabilities measured at fair value on a recurring basis. June 30, 2016 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US government agencies $ 22,183 $ — $ 22,183 $ — Residential mortgage-backed securities 42,603 — 42,603 — Mutual fund 2,018 — 2,018 — Servicing assets 1 48,454 — — 48,454 Total assets at fair value $ 115,258 $ — $ 66,804 $ 48,454 December 31, 2015 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US government agencies $ 22,068 $ — $ 22,068 $ — Residential mortgage-backed securities 29,758 — 29,758 — Mutual fund 1,936 — 1,936 — Servicing assets 1 44,230 — — 44,230 Total assets at fair value $ 97,992 $ — $ 53,762 $ 44,230 1 See Note 6 for a rollforward of recurring Level 3 fair values for servicing assets. Non-recurring Fair Value The tables below present the recorded amount of assets and liabilities measured at fair value on a non-recurring basis. June 30, 2016 Total Level 1 Level 2 Level 3 Impaired loans $ 18,276 $ — $ — $ 18,276 Foreclosed assets 2,971 — — 2,971 Total assets at fair value $ 21,247 $ — $ — $ 21,247 December 31, 2015 Total Level 1 Level 2 Level 3 Impaired loans $ 17,084 $ — $ — $ 17,084 Foreclosed assets 2,666 — — 2,666 Total assets at fair value $ 19,750 $ — $ — $ 19,750 Level 3 Analysis For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of June 30, 2016 and December 31, 2015 the significant unobservable inputs used in the fair value measurements were as follows: June 30, 2016 Level 3 Assets with Significant Unobservable Inputs Fair Value Valuation Technique Significant Unobservable Inputs Range Impaired Loans $ 18,276 Discounted appraisals Appraisal adjustments (1) Interest rate & repayment term 1% to 25% Weighted average discount rate 5.49% Foreclosed Assets $ 2,971 Discounted appraisals Appraisal adjustments (1) 10% to 35% December 31, 2015 Level 3 Assets with Significant Unobservable Inputs Fair Value Valuation Technique Significant Unobservable Inputs Range Impaired Loans $ 17,084 Discounted appraisals Appraisal adjustments (1) Interest rate & repayment term 10% to 20% Weighted average discount rate 5.57% Foreclosed Assets $ 2,666 Discounted appraisals Appraisal adjustments (1) 10% to 20% (1) Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments. Estimated Fair Value of Other Financial Instruments GAAP also requires disclosure of fair value information about financial instruments carried at book value on the balance sheet. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. In that regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, could not be realized in immediate settlement of the instruments. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments not measured at fair value on the balance sheets: Cash and due from banks : The carrying amounts reported in the balance sheet for cash and due from banks approximate their fair values. Certificates of deposit with other banks : The fair value of certificates of deposit with other banks is estimated based on discounting cash flows using the rates currently offered for instruments of similar remaining maturities. Loans held for sale: The fair values of loans held for sale are based on quoted market prices, where available, and determined by discounting estimated cash flows using interest rates approximating the Company’s current origination rates for similar loans adjusted to reflect the inherent credit risk. Loans held for investment : For variable-rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying amounts. The fair values for other loans are estimated using discounted cash flow analysis, based on interest rates currently being offered for loans with similar terms to borrowers of similar credit quality. Loan fair value estimates include judgments regarding future expected loss experience and risk characteristics. Fair values for impaired loans are estimated using discounted cash flow analysis or underlying collateral values, where applicable. Accrued interest: The carrying amounts of accrued interest approximate fair value. Deposits : The fair values disclosed for demand deposits (e.g., interest and non-interest checking, passbook savings, and certain types of money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). The carrying amounts of variable-rate, fixed-term money market accounts and certificates of deposit approximate their fair values at the reporting date. Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered on certificates to a schedule of aggregated expected monthly maturities on time deposits. Short and long term borrowings: The fair values of the Company’s short term borrowings approximate fair value while long term borrowings are estimated using discounted cash flow analyses based on the Company’s current incremental debt rates for similar types of debt arrangements. The carrying amounts and estimated fair values of the Company’s financial instruments are as follows: June 30, 2016 Carrying Amount Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Fair Value Financial assets Cash and due from banks $ 175,506 $ 175,506 $ — $ — $ 175,506 Certificates of deposit with other banks 8,500 8,513 — — 8,513 Investment securities, available-for-sale 66,804 — 66,804 — 66,804 Loans held for sale 329,206 — — 361,520 361,520 Loans, net of allowance for loan losses 678,208 — — 672,526 672,526 Servicing assets 48,454 — — 48,454 48,454 Accrued interest receivable 6,304 6,304 — — 6,304 Financial liabilities Deposits 1,140,797 — 1,148,570 — 1,148,570 Accrued interest payable 202 202 — — 202 Long term borrowings 28,173 — — 31,044 31,044 December 31, 2015 Carrying Amount Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Fair Value Financial assets Cash and due from banks $ 102,607 $ 102,607 $ — $ — $ 102,607 Certificates of deposit with other banks 10,250 10,176 — — 10,176 Investment securities, available-for-sale 53,762 — 53,762 — 53,762 Loans held for sale 480,619 — — 497,868 497,868 Loans, net of allowance for loan losses 272,554 — — 268,816 268,816 Servicing assets 44,230 — — 44,230 44,230 Accrued interest receivable 5,556 5,556 — — 5,556 Financial liabilities Deposits 804,788 — 792,820 — 792,820 Accrued interest payable 211 211 — — 211 Long term borrowings 28,375 — — 30,523 30,523 Loans held for sale that are carried at the lower of cost or estimated fair value as of June 30, 2016 significantly declined compared to December 31, 2015 because $318.8 million of these loans were reclassified to loans held for investment.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation In the normal course of business the Company is involved in various legal proceedings. Management believes that the outcome of such proceedings will not materially affect the financial position, results of operations or cash flows of the Company. Financial Instruments with Off-balance-sheet Risk The Company is party to financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. These instruments involve, to varying degrees, credit risk in excess of the amount recognized in the balance sheet. The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as for on-balance-sheet instruments. A summary of the Company’s commitments is as follows: June 30, December 31, Commitments to extend credit $ 1,185,541 $ 737,572 Standby letters of credit 343 — Plexus Capital - Fund II Investment Commitment 100 100 Plexus Capital - Fund III Investment Commitment 250 300 Five Points Mezzanine Fund III Commitment 1,464 1,500 Total unfunded off-balance sheet credit risk $ 1,187,698 $ 739,472 Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The Company evaluates each customer’s creditworthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the party. Collateral held varies, but may include accounts receivable, inventory, property and equipment, residential real estate and income-producing commercial properties. In 2012, the Company began issuing commitment letters after approval of the loan by the Credit Department. Commitment letters generally expire ninety days after issuance. Standby letters of credit are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. Those guarantees are primarily issued to support public and private borrowing arrangements. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. Collateral held varies as specified above and is required in instances which the Company deems necessary. Concentrations of Credit Risk Although the Company is not subject to any geographic concentrations, a substantial amount of the Company’s loans and commitments to extend credit have been granted to customers in the independent pharmacy and veterinary verticals. The concentrations of credit by type of loan are set forth in Note 5 . The distribution of commitments to extend credit approximates the distribution of loans outstanding. The Company does not have a significant number of credits to any single borrower or group of related borrowers whereby their retained unguaranteed exposure exceeds $ 2.0 million , except for seven relationships that have a retained unguaranteed exposure of $ 21.0 million . The Company from time-to-time may have cash and cash equivalents on deposit with financial institutions that exceed federally-insured limits.

Stock Plans

Stock Plans	6 Months Ended
	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Plans	Stock Plans On March 20, 2015, the Company adopted the 2015 Omnibus Stock Incentive Plan which replaced the previously existing Amended Incentive Stock Option Plan and Nonstatutory Stock Option Plan. Subsequently on May 24, 2016, the 2015 Omnibus Stock Incentive Plan was amended to authorize awards covering a maximum of 7,000,000 common voting shares and has an expiration date of March 20, 2025 . Options or restricted shares granted under the Amended and Restated 2015 Omnibus Stock Incentive Plan (the "Plan") expire no more than 10 years from the date of grant. Exercise prices under the Plan are set by the Board of Directors at the date of grant, but shall not be less than 100% of fair market value of the related stock at the date of the grant. Options or restricted shares vest over a minimum of three years from the date of the grant. Stock Options Compensation cost relating to share-based payment transactions are recognized in the financial statements with measurement based upon the fair value of the equity or liability instruments issued. For the three months ended June 30, 2016 and 2015 , the Company recognized $ 581 thousand and $ 177 thousand in compensation expense for stock options, respectively. For the six months ended June 30, 2016 and 2015 , the Company recognized $ 1.2 million and $ 295 thousand in compensation expense for stock options, respectively. Stock option activity under the plan during the six month periods ended June 30, 2016 and 2015 is summarized below. Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2015 3,546,992 $ 11.17 Exercised 16,707 6.39 Forfeited 107,594 8.12 Granted 169,987 14.02 Outstanding at June 30, 2016 3,592,678 $ 11.41 8.55 years $ 13,895,411 Exercisable at June 30, 2016 333,066 $ 5.79 7.69 years $ 2,772,308 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Terms Aggregate Intrinsic Value Outstanding at December 31, 2014 1,737,570 $ 5.51 Exercised 34,930 4.40 Forfeited 66,319 4.88 Granted 636,505 11.70 Outstanding at June 30, 2015 2,272,826 $ 7.28 9.03 years $ 15,277,131 Exercisable at June 30, 2015 149,258 $ 3.76 8.20 years $ 1,528,763 The following is a summary of non-vested stock option activity for the Company for the six months ended June 30, 2016 and 2015 . Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2015 3,393,441 $ 4.56 Granted 169,987 6.58 Vested 196,222 1.48 Forfeited 107,594 2.54 Non-vested at June 30, 2016 3,259,612 $ 4.89 Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2014 1,704,230 $ 1.18 Granted 636,505 4.59 Vested 150,848 0.54 Forfeited 66,319 0.83 Non-vested at June 30, 2015 2,123,568 $ 2.26 The total intrinsic value of options exercised at June 30, 2016 and 2015 was $ 144 thousand and $ 218 thousand , respectively. At June 30, 2016 , unrecognized compensation costs relating to stock options amounted to $ 13.9 million which will be recognized over a weighted average period of 3.60 years. The weighted average fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The expected volatility is based on historical volatility. The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life is based on historical exercise experience. The dividend yield assumption is based on the Company’s history and expectation of dividend payouts. Weighted average assumptions used for options granted during 2016 were as follows: risk free rate of 1.56% , dividend yield of 0.05% , volatility of 44.20% and average life of 7 years . Restricted Stock Restricted stock awards are authorized in the form of restricted stock awards or units ("RSU"s) and restricted stock awards or units with a market price condition ("Market RSU"s). RSUs have a restriction based on the passage of time and may also have a restriction based on a non-market-related performance criteria. The fair value of the RSUs is based on the closing price on the date of the grant. Market RSUs also have a restriction based on the passage of time and non-market-related performance criteria, but also have a restriction based on market price criteria related to the Company’s share price closing at or above $34.00 per share for at least twenty (20) consecutive trading days at any time prior to March 23, 2023. The amount of Market RSUs earned will not exceed 100% of the Market RSUs awarded. The fair value of the Market RSUs is calculated using the Monte Carlo Simulation method. RSU stock activity under the plan during the first six months of 2016 is summarized below. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2015 64,271 $ 16.17 Granted 520,744 15.86 Vested 2,776 10.63 Forfeited 447 10.63 Non-vested at June 30, 2016 581,792 $ 15.92 For the three months ended June 30, 2016 and 2015 , the Company recognized $ 2.1 million and $8 thousand in compensation expense for RSUs, respectively. For the six months ended June 30, 2016 and 2015 , the Company recognized $ 2.2 million and $ 16 thousand in compensation expense for RSUs, respectively. At June 30, 2016 , unrecognized compensation costs relating to RSUs amounted to $ 7.0 million which will be recognized over a weighted average period of 0.77 years. Market RSU stock activity under the plan during the first six months of 2016 is summarized below. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2015 — $ — Granted 850,000 7.06 Vested — — Forfeited — — Non-vested at June 30, 2016 850,000 $ 7.06 The compensation expense for Market RSUs is measured based on their grant date fair value as calculated using the Monte Carlo Simulation and is recognized on a straight-line basis over the average vesting period. Related to the 850,000 Market RSUs granted during the six months ended June 30, 2016, the Monte Carlo Simulation used 100,000 simulation paths to assess the expected date of achieving the market price criteria. The share price simulation was based on the Cox, Ross & Rubinstein option pricing methodology for a period of 6.83 years. The implied term of the restricted stock was 4.2 years. The Monte Carlo Simulation used various assumptions that include a risk free rate of return of 1.68% , expected volatility of 30.00% and a dividend yield of 0.25% . For the three and six months ended June 30, 2016 , the Company recognized $ 231 thousand in compensation expense for Market RSUs. All of the Company's Market RSUs had an effective grant date of May 24, 2016. At June 30, 2016 , unrecognized compensation costs relating to Market RSUs amounted to $ 5.8 million which will be recognized over a weighted average period of 4.17 years.

Basis of Presentation (Policies

Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting	In the opinion of management, all adjustments necessary for a fair presentation of the financial position and results of operations for the periods presented have been included, and all intercompany transactions have been eliminated in consolidation. Results of operations for the six months ended June 30, 2016 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2016 . The consolidated balance sheet as of December 31, 2015 has been derived from the audited consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015 , filed with the Securities Exchange Commission on March 14, 2016 (SEC File No. 001-37497) (the "2015 Annual Report"). A summary description of the significant accounting policies followed by the Company is set forth in Note 1 of the Notes to Consolidated Financial Statements in the Company’s 2015 Annual Report. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes in the Company's 2015 Annual Report. The preparation of financial statements in conformity with United States generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. Amounts in all tables in the Notes to Unaudited Consolidated Financial Statements have been presented in thousands, except percentage, time period, stock option, share and per share data or where otherwise indicated.
Business Segments	Business Segments Management has determined that the Company has one significant operating segment, which is providing a lending platform for small businesses nationwide. In determining the appropriateness of segment definition, the Company considers the materiality of a potential segment, the components of the business about which financial information is available, and components for which management regularly evaluates relative to resource allocation and performance assessment.
Loans Reclassified to Held for Investment	Loans Reclassified to Held for Investment Loans receivable that management has the intent and ability to hold for the foreseeable future or until maturity or pay-off are classified as held for investment ("HFI") and reported at their outstanding principal amount adjusted for any charge-offs, the allowance for loan losses, and any deferred fees or costs on originated loans and unamortized premium or discount on purchased loans. Loan origination fees, net of certain direct origination costs, are deferred and recognized as an adjustment of the related loan yield using the interest method. Loans originated and intended for sale are classified as held for sale ("HFS") and carried at the lower of cost or estimated fair value. During the second quarter of 2016, the Bank transferred $318.8 million in unguaranteed loans from the HFS category to the HFI category to better reflect intentions of the Company.
Allowance for Loan Losses	Allowance for Loan Losses The allowance for loan losses is established as losses are estimated to have occurred through a provision for loan losses charged to earnings. Loan losses are charged against the allowance when management believes the un-collectibility of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the allowance. The allowance for loan losses is evaluated on a regular basis by management and is based upon management’s periodic review of the collectibility of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as more information becomes available. Upon transfer from held for sale classification, loans held for investment become subject to the allowance for loan loss review process. As a result of this process, the above mentioned $318.8 million loan reclassification resulted in a $4.0 million increase in the provision for loan losses during the second quarter of 2016. During the second quarter of 2016, the Company also implemented enhancements to the methodology for estimating the allowance for loan losses, including refinements to the measurement of qualitative factors in the estimation process. Management believes these enhancements will improve the precision of the process for estimating the allowance, but did not fundamentally change the Company's approach. These revisions resulted in a $390 thousand reduction in the provision for loan losses during the second quarter of 2016.
Reclassifications	Reclassifications Certain reclassifications have been made to the prior period’s consolidated financial statements to place them on a comparable basis with the current year. Net income and shareholders’ equity previously reported were not affected by these reclassifications.
Recent Accounting Pronouncements	In March 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-08, “Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)” (“ASU 2016-08”). This guidance amends the previously issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2016-08 clarifies the implementation guidance on principal versus agent considerations in order to determine if revenue will be recognized on a gross or net basis. This guidance is effective for the Company on January 1, 2018 and is not expected to have a material impact on the consolidated financial statements. In March 2016, the FASB issued ASU No. 2016-09, “Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (“ASU 2016-09”). ASU 2016-09 simplifies the accounting for share-based payment transactions for items including income tax consequences, classification of awards as equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 will be effective for the Company on January 1, 2017 and the Company is currently assessing the impact the adoption of this standard will have on the consolidated financial statements. In April 2016, the FASB issued ASU No. 2016-10, "Identifying Performance Obligations and Licensing" ("ASU 2016-10"). This guidance amends the previously issued ASU No. 2014-09, "Revenue from Contracts with Customers (Topic 606)" ("ASU 2014-09"). ASU 2016-10 clarifies the guidance related to identifying performance obligations and accounting for licenses of intellectual property. The amendments will be effective for the Company on January 1, 2018. The Company does not expect these amendments to have a material effect on its consolidated financial statements. In May 2016, the FASB issued ASU 2016-12, "Narrow-Scope Improvements and Practical Expedients" ("ASU 2016-12"). This guidance also amends the previously issued ASU No. 2014-09 to clarify guidance related to collectibility, noncash consideration, presentation of sales tax and transition. The amendments will be effective for the Company on January 1, 2018. The Company does not expect these amendments to have a material effect on its consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, "Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13"). This new guidance replaces the incurred loss impairment methodology in current standards with an expected credit loss methodology and requires consideration of a broader range of information to determine credit loss estimates. ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts and requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. ASU 2016-13 will be effective for the Company on January 1, 2020. The Company is currently evaluating the effect the implementation of the new standard will have on its consolidated financial statements.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2016
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Earnings Per Share	Basic and diluted earnings per share are computed based on the weighted average number of shares outstanding during each period. Diluted earnings per share reflects the potential dilution that could occur, upon the exercise of stock options or upon the vesting of restricted stock grants, any of which would result in the issuance of common stock that would then be shared in the net income of the Company. Three Months Ended Six Months Ended 2016 2015 2016 2015 Basic earnings per share: Net income available to common shareholders $ 123 $ 3,935 $ 4,814 $ 12,008 Weighted-average basic shares outstanding 34,189,217 28,636,182 34,183,004 28,628,177 Basic earnings per share $ 0.00 $ 0.14 $ 0.14 $ 0.42 Diluted earnings per share: Net income available to common shareholders, for diluted earnings per share $ 123 $ 3,935 $ 4,814 $ 12,008 Total weighted-average basic shares outstanding 34,189,217 28,636,182 34,183,004 28,628,177 Add effect of dilutive stock options and restricted stock grants 1,016,908 862,217 896,656 811,645 Total weighted-average diluted shares outstanding 35,206,125 29,498,399 35,079,660 29,439,822 Diluted earnings per share $ 0.00 $ 0.13 $ 0.14 $ 0.41 Anti-dilutive shares 1,807,823 916,199 1,807,823 956,199

Securities (Tables)

Securities (Tables)	6 Months Ended
	Jun. 30, 2016
Investments, Debt and Equity Securities [Abstract]
Summary of Carrying Amount and Fair Value of Securities	The carrying amount of securities and their approximate fair values are reflected in the following table: Amortized Cost Unrealized Gains Unrealized Losses Fair Value June 30, 2016 US government agencies $ 22,018 $ 165 $ — $ 22,183 Residential mortgage-backed securities 42,478 161 36 42,603 Mutual fund 1,981 37 — 2,018 Total $ 66,477 $ 363 $ 36 $ 66,804 December 31, 2015 US government agencies $ 21,992 $ 81 $ 5 $ 22,068 Residential mortgage-backed securities 30,131 1 374 29,758 Mutual fund 1,951 — 15 1,936 Total $ 54,074 $ 82 $ 394 $ 53,762
Summary of Gross Unrealized Losses and Fair Value	The following tables show gross unrealized losses and fair value, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position. Less Than 12 Months 12 Months or More Total June 30, 2016 Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Residential mortgage-backed securities $ 2,401 $ 16 $ 5,494 $ 20 $ 7,895 $ 36 Total $ 2,401 $ 16 $ 5,494 $ 20 $ 7,895 $ 36 Less Than 12 Months 12 Months or More Total December 31, 2015 Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses US government agencies $ 7,990 $ 5 $ — $ — $ 7,990 $ 5 Residential mortgage-backed securities 26,015 333 3,019 41 29,034 374 Mutual fund 1,936 15 — — 1,936 15 Total $ 35,941 $ 353 $ 3,019 $ 41 $ 38,960 $ 394
Summary of Investment Securities by Maturity	The following is a summary of investment securities by maturity: June 30, 2016 Available-for-Sale Amortized cost Fair value US government agencies Within one year $ 9,210 $ 9,227 One to five years 12,808 12,956 Total 22,018 22,183 Residential mortgage-backed securities Five to ten years 8,324 8,402 After 10 years 34,154 34,201 Total 42,478 42,603 Total $ 64,496 $ 64,786

Loans Held for Investment and21

Loans Held for Investment and Allowance for Loan Losses (Tables)	6 Months Ended
	Jun. 30, 2016
Receivables [Abstract]
Summary of Loans	Loans consist of the following: June 30, December 31, Commercial & Industrial Agriculture $ 463 $ 30 Death Care Management 9,753 4,832 Healthcare 32,959 15,240 Independent Pharmacies 77,818 41,588 Registered Investment Advisors 54,091 18,358 Veterinary Industry 37,584 21,579 Other Industries 32,010 3,230 Total 244,678 104,857 Construction & Development Agriculture 35,041 11,351 Death Care Management 2,455 769 Healthcare 23,561 7,231 Independent Pharmacies 2,081 101 Registered Investment Advisors 703 378 Veterinary Industry 10,534 3,834 Other Industries 11,477 658 Total 85,852 24,322 Commercial Real Estate Agriculture 5,672 1,863 Death Care Management 45,162 20,327 Healthcare 95,146 37,684 Independent Pharmacies 13,650 7,298 Registered Investment Advisors 6,787 2,808 Veterinary Industry 96,162 59,999 Other Industries 23,739 4,752 Total 286,318 134,731 Commercial Land Agriculture 72,643 16,036 Total 72,643 16,036 Total Loans 1 689,491 279,946 Net Deferred Costs 6,902 3,056 Discount on SBA 7(a) Unguaranteed 2 (5,876 ) (3,033 ) Loans, Net of Unearned $ 690,517 $ 279,969 1 Total loans include $ 28.5 million and $ 17.2 million of U.S. government guaranteed loans as of June 30, 2016 and December 31, 2015 , respectively. 2 The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales.
Summary of Risk Grades of Each Category of Loans	The following tables summarize the risk grades of each category: Risk Grades 1 - 4 Risk Grade 5 Risk Grades 6 - 8 Total June 30, 2016 Commercial & Industrial Agriculture $ 406 $ 57 $ — $ 463 Death Care Management 9,518 226 9 9,753 Healthcare 25,201 3,362 4,396 32,959 Independent Pharmacies 72,619 3,620 1,579 77,818 Registered Investment Advisors 52,617 1,101 373 54,091 Veterinary Industry 33,504 1,883 2,197 37,584 Other Industries 32,010 — — 32,010 Total 225,875 10,249 8,554 244,678 Construction & Development Agriculture 35,041 — — 35,041 Death Care Management 2,049 406 — 2,455 Healthcare 21,340 2,221 — 23,561 Independent Pharmacies 2,081 — — 2,081 Registered Investment Advisors 703 — — 703 Veterinary Industry 9,341 1,193 — 10,534 Other Industries 11,477 — — 11,477 Total 82,032 3,820 — 85,852 Commercial Real Estate Agriculture 5,672 — — 5,672 Death Care Management 41,173 2,405 1,584 45,162 Healthcare 88,389 5,724 1,033 95,146 Independent Pharmacies 12,053 1,597 — 13,650 Registered Investment Advisors 6,787 — — 6,787 Veterinary Industry 81,384 4,096 10,682 96,162 Other Industries 23,739 — — 23,739 Total 259,197 13,822 13,299 286,318 Commercial Land Agriculture 70,636 1,890 117 72,643 Total 70,636 1,890 117 72,643 Total 1 $ 637,740 $ 29,781 $ 21,970 $ 689,491 Risk Grades 1 - 4 Risk Grade 5 Risk Grades 6 - 8 Total December 31, 2015 Commercial & Industrial Agriculture $ 30 $ — $ — $ 30 Death Care Management 4,728 104 — 4,832 Healthcare 8,334 2,160 4,746 15,240 Independent Pharmacies 36,704 3,430 1,454 41,588 Registered Investment Advisors 17,508 850 — 18,358 Veterinary Industry 16,800 1,817 2,962 21,579 Other Industries 3,089 141 — 3,230 Total 87,193 8,502 9,162 104,857 Construction & Development Agriculture 11,194 157 — 11,351 Death Care Management 769 — — 769 Healthcare 7,231 — — 7,231 Independent Pharmacies 101 — — 101 Registered Investment Advisors 378 — — 378 Veterinary Industry 2,581 1,253 — 3,834 Other Industries 658 — — 658 Total 22,912 1,410 — 24,322 Commercial Real Estate Agriculture 1,863 — — 1,863 Death Care Management 18,223 425 1,679 20,327 Healthcare 33,529 2,930 1,225 37,684 Independent Pharmacies 6,210 1,088 — 7,298 Registered Investment Advisors 2,808 — — 2,808 Veterinary Industry 45,453 3,171 11,375 59,999 Other Industries 4,752 — — 4,752 Total 112,838 7,614 14,279 134,731 Commercial Land Agriculture 16,036 — — 16,036 Total 16,036 — — 16,036 Total 1 $ 238,979 $ 17,526 $ 23,441 $ 279,946 1 Total loans include $ 28.5 million of U.S. government guaranteed loans as of June 30, 2016 , segregated by risk grade as follows: Risk Grades 1 – 4 = $ 7.7 million, Risk Grade 5 = $ 7.6 million , Risk Grades 6 – 8 = $ 13.2 million . As of December 31, 2015 , total loans include $ 17.2 million of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $ 0 , Risk Grade 5 = $ 2.6 million , Risk Grades 6 – 8 = $ 14.6 million .
Summary of Age Analysis of Past Due Loans	The following tables show an age analysis of past due loans as of the dates presented. Less Than 30 Days Past Due & Not Accruing 30-89 Days Past Due & Accruing 30-89 Days Past Due & Not Accruing Greater Than 90 Days Past Due Total Not Accruing & Past Due Loans Current Loans Total Loans Loans 90 Days or More Past Due & Still Accruing June 30, 2016 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 463 $ 463 $ — Death Care Management — — — — — 9,753 9,753 — Healthcare — 576 487 2,219 3,282 29,677 32,959 — Independent Pharmacies 294 415 156 270 1,135 76,683 77,818 — Registered Investment Advisors — — — — — 54,091 54,091 — Veterinary Industry 90 — 690 1,054 1,834 35,750 37,584 — Other Industries — — — — — 32,010 32,010 — Total 384 991 1,333 3,543 6,251 238,427 244,678 — Construction & Development Agriculture — — — — — 35,041 35,041 — Death Care Management — — — — — 2,455 2,455 — Healthcare — — — — — 23,561 23,561 — Independent Pharmacies — — — — — 2,081 2,081 — Registered Investment Advisors — — — — — 703 703 — Veterinary Industry — — — — — 10,534 10,534 — Other Industries — — — — — 11,477 11,477 — Total — — — — — 85,852 85,852 — Commercial Real Estate Agriculture — — — — — 5,672 5,672 — Death Care Management — 221 — 1,423 1,644 43,518 45,162 — Healthcare 350 258 — 209 817 94,329 95,146 — Independent Pharmacies — — — — — 13,650 13,650 — Registered Investment Advisors — — — — — 6,787 6,787 — Veterinary Industry 2,224 4,284 — 3,319 9,827 86,335 96,162 — Other Industries — — — — — 23,739 23,739 — Total 2,574 4,763 — 4,951 12,288 274,030 286,318 — Commercial Land Agriculture 117 — — — 117 72,526 72,643 — Total 117 — — — 117 72,526 72,643 — Total 1 $ 3,075 $ 5,754 $ 1,333 $ 8,494 $ 18,656 $ 670,835 $ 689,491 $ — Less Than 30 Days Past Due & Not Accruing 30-89 Days Past Due & Accruing 30-89 Days Past Due & Not Accruing Greater Than 90 Days Past Due Total Not Accruing & Past Due Loans Current Loans Total Loans Loans 90 Days or More Past Due & Still Accruing December 31, 2015 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 30 $ 30 $ — Death Care Management — — — — — 4,832 4,832 — Healthcare — 1,854 30 2,337 4,221 11,019 15,240 — Independent Pharmacies 314 603 — — 917 40,671 41,588 — Registered Investment Advisors — — — — — 18,358 18,358 — Veterinary Industry 208 466 1,131 394 2,199 19,380 21,579 — Other Industries — — — — — 3,230 3,230 — Total 522 2,923 1,161 2,731 7,337 97,520 104,857 — Construction & Development Agriculture — — — — — 11,351 11,351 — Death Care Management — — — — — 769 769 — Healthcare — — — — — 7,231 7,231 — Independent Pharmacies — — — — — 101 101 — Registered Investment Advisors — — — — — 378 378 — Veterinary Industry — — — — — 3,834 3,834 — Other Industries — — — — — 658 658 — Total — — — — — 24,322 24,322 — Commercial Real Estate Agriculture — — — — — 1,863 1,863 — Death Care Management 1,456 223 — — 1,679 18,648 20,327 — Healthcare — 240 135 831 1,206 36,478 37,684 — Independent Pharmacies — — — — — 7,298 7,298 — Registered Investment Advisors — — — — — 2,808 2,808 — Veterinary Industry 311 5,079 2,048 3,172 10,610 49,389 59,999 — Other Industries — — — — — 4,752 4,752 — Total 1,767 5,542 2,183 4,003 13,495 121,236 134,731 — Commercial Land Agriculture — — — — — 16,036 16,036 — Total — — — — — 16,036 16,036 — Total 1 $ 2,289 $ 8,465 $ 3,344 $ 6,734 $ 20,832 $ 259,114 $ 279,946 $ — 1 Total loans include $ 28.5 million of U.S. government guaranteed loans as of June 30, 2016 , of which $ 7.4 million is greater than 90 days past due, $ 3.5 million is 30-89 days past due and $ 17.6 million is included in current loans as presented above. As of December 31, 2015 , total loans include $ 17.2 million of U.S. government guaranteed loans, of which $ 5.9 million is greater than 90 days past due, $ 6.7 million is 30-89 days past due and $ 4.6 million is included in current loans as presented above.
Schedule of Nonaccrual Loans	Nonaccrual loans as of June 30, 2016 and December 31, 2015 are as follows: June 30, 2016 Loan Balance Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 2,706 $ 2,463 $ 243 Independent Pharmacies 720 558 162 Veterinary Industry 1,834 1,688 146 Total 5,260 4,709 551 Commercial Real Estate Death Care Management 1,423 1,264 159 Healthcare 559 306 253 Veterinary Industry 5,543 4,332 1,211 Total 7,525 5,902 1,623 Commercial Land Agriculture 117 117 — Total 117 117 — Total $ 12,902 $ 10,728 $ 2,174 December 31, 2015 Loan Balance Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 2,367 $ 2,188 $ 179 Independent Pharmacies 314 308 6 Veterinary Industry 1,733 1,572 161 Total 4,414 4,068 346 Commercial Real Estate Death Care Management 1,456 1,290 166 Healthcare 966 798 168 Veterinary Industry 5,531 4,174 1,357 Total 7,953 6,262 1,691 Total $ 12,367 $ 10,330 $ 2,037
Schedule of Allowance for Loan Losses by Portfolio Segment Allowance	The following table details activity in the allowance for loan losses by portfolio segment allowance for the periods presented: Three months ended: Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total June 30, 2016 Beginning Balance $ 1,163 $ 2,575 $ 3,345 $ 1,533 $ 8,616 Charge offs — — (100 ) (63 ) (163 ) Recoveries — 3 400 — 403 Provision 45 1,501 1,956 (49 ) 3,453 Ending Balance $ 1,208 $ 4,079 $ 5,601 $ 1,421 $ 12,309 June 30, 2015 Beginning Balance $ 755 $ 2,062 $ 2,063 $ 354 $ 5,234 Charge offs — (42 ) (186 ) — (228 ) Recoveries — 87 40 — 127 Provision 89 239 (264 ) (14 ) 50 Ending Balance $ 844 $ 2,346 $ 1,653 $ 340 $ 5,183 Six months ended: Construction & Commercial Commercial Commercial Total June 30, 2016 Beginning Balance $ 1,064 $ 2,486 $ 2,766 $ 1,099 $ 7,415 Charge offs — (7 ) (368 ) (63 ) (438 ) Recoveries — 3 443 — 446 Provision 144 1,597 2,760 385 4,886 Ending Balance $ 1,208 $ 4,079 $ 5,601 $ 1,421 $ 12,309 June 30, 2015 Beginning Balance $ 586 $ 2,291 $ 1,369 $ 161 $ 4,407 Charge offs — (121 ) (358 ) — (479 ) Recoveries — 88 40 — 128 Provision 258 88 602 179 1,127 Ending Balance $ 844 $ 2,346 $ 1,653 $ 340 $ 5,183 The following tables detail the recorded allowance for loan losses and the investment in loans related to each portfolio segment, disaggregated on the basis of impairment evaluation methodology: June 30, 2016 Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total Allowance for Loan Losses: Loans individually evaluated for impairment $ — $ 874 $ 996 $ — $ 1,870 Loans collectively evaluated for impairment 2 1,208 3,205 4,605 1,421 10,439 Total allowance for loan losses $ 1,208 $ 4,079 $ 5,601 $ 1,421 $ 12,309 Loans receivable 1 : Loans individually evaluated for impairment $ — $ 11,536 $ 3,320 $ — $ 14,856 Loans collectively evaluated for impairment 2 85,852 274,782 241,358 72,643 674,635 Total loans receivable $ 85,852 $ 286,318 $ 244,678 $ 72,643 $ 689,491 December 31, 2015 Construction & Development Commercial Real Estate Commercial & Industrial Commercial Land Total Allowance for Loan Losses: Loans individually evaluated for impairment $ — $ 1,090 $ 672 $ — $ 1,762 Loans collectively evaluated for impairment 2 1,064 1,396 2,094 1,099 5,653 Total allowance for loan losses $ 1,064 $ 2,486 $ 2,766 $ 1,099 $ 7,415 Loans receivable 1 : Loans individually evaluated for impairment $ — $ 9,821 $ 3,226 $ — $ 13,047 Loans collectively evaluated for impairment 2 24,322 124,910 101,631 16,036 266,899 Total loans receivable $ 24,322 $ 134,731 $ 104,857 $ 16,036 $ 279,946 1 Loans receivable includes $ 28.5 million of U.S. government guaranteed loans as of June 30, 2016 , of which $ 13.3 million are impaired. As of December 31, 2015 , loans receivable includes $ 17.2 million of U.S. government guaranteed loans, of which $ 14.1 million are considered impaired. 2 Included in loans collectively evaluated for impairment are impaired loans with individual unguaranteed exposure of less than $100 thousand. As of June 30, 2016 , these balances totaled $ 9.3 million , of which $ 7.4 million are guaranteed by the U.S. government and $ 1.9 million are unguaranteed. As of December 31, 2015 , these balances totaled $ 8.6 million , of which $ 7.5 million are guaranteed by the U.S. government and $ 1.1 million are unguaranteed. The allowance for loan losses associated with these loans totaled $ 589 thousand and $ 352 thousand as of June 30, 2016 and December 31, 2015 , respectively.
Summary of Loans Individually Evaluated for Impairment	Loans classified as impaired as of the dates presented are summarized in the following tables. June 30, 2016 Recorded Investment Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Death Care Management $ 9 $ — $ 9 Healthcare 4,405 2,463 1,942 Independent Pharmacies 1,918 870 1,048 Registered Investment Advisors 376 — 376 Veterinary Industry 2,553 1,829 724 Total 9,261 5,162 4,099 Commercial Real Estate Death Care Management 1,582 1,264 318 Healthcare 1,032 306 726 Veterinary Industry 12,130 6,480 5,650 Total 14,744 8,050 6,694 Commercial Land Agriculture 117 117 — Total 117 117 — Total $ 24,122 $ 13,329 $ 10,793 December 31, 2015 Recorded Investment Guaranteed Balance Unguaranteed Exposure Commercial & Industrial Healthcare $ 4,442 $ 3,341 $ 1,101 Independent Pharmacies 1,546 637 909 Veterinary Industry 2,256 1,731 525 Total 8,244 5,709 2,535 Commercial Real Estate Death Care Management 1,454 1,290 164 Healthcare 965 799 166 Veterinary Industry 11,003 6,349 4,654 Total 13,422 8,438 4,984 Total $ 21,666 $ 14,147 $ 7,519
Schedule of Evaluated Balances of Loans Classified as Impaired	The following table presents evaluated balances of loans classified as impaired at the dates presented that carried an associated reserve as compared to those with no reserve. The recorded investment includes accrued interest and net deferred loan fees or costs. June 30, 2016 Recorded Investment With a Recorded Allowance With No Recorded Allowance Total Unpaid Principal Balance Related Allowance Recorded Commercial & Industrial Death Care Management $ 9 $ — $ 9 $ 9 $ 3 Healthcare 4,139 266 4,405 4,461 671 Independent Pharmacies 1,737 181 1,918 2,012 338 Registered Investment Advisors 376 — 376 373 44 Veterinary Industry 2,553 — 2,553 2,934 285 Total 8,814 447 9,261 9,789 1,341 Commercial Real Estate Death Care Management 1,582 — 1,582 1,718 54 Healthcare 903 129 1,032 1,033 142 Veterinary Industry 9,319 2,811 12,130 12,886 921 Total 11,804 2,940 14,744 15,637 1,117 Commercial Land Agriculture 117 — 117 180 1 Total 117 — 117 180 1 Total Impaired Loans $ 20,735 $ 3,387 $ 24,122 $ 25,606 $ 2,459 December 31, 2015 Recorded Investment With a Recorded Allowance With No Recorded Allowance Total Unpaid Principal Balance Related Allowance Recorded Commercial & Industrial Healthcare $ 4,242 $ 200 $ 4,442 $ 4,742 $ 478 Independent Pharmacies 1,199 347 1,546 2,041 287 Veterinary Industry 2,051 205 2,256 3,270 138 Total 7,492 752 8,244 10,053 903 Commercial Real Estate Death Care Management 1,454 — 1,454 1,591 9 Healthcare 965 — 965 1,096 96 Veterinary Industry 9,265 1,738 11,003 11,856 1,106 Total 11,684 1,738 13,422 14,543 1,211 Total Impaired Loans $ 19,176 $ 2,490 $ 21,666 $ 24,596 $ 2,114 Three months ended Three months ended Average Interest Average Interest Commercial & Industrial Death Care Management $ 9 $ — $ — $ — Healthcare 4,440 21 3,320 25 Independent Pharmacies 1,935 17 3,751 13 Registered Investment Advisors 379 5 — — Veterinary Industry 2,640 9 2,864 5 Total 9,403 52 9,935 43 Commercial Real Estate Death Care Management 1,582 2 1,418 — Healthcare 1,038 7 2,502 — Veterinary Industry 12,189 84 13,530 51 Total 14,809 93 17,450 51 Commercial Land Agriculture 335 — — — Total 335 — — — Total $ 24,547 $ 145 $ 27,385 $ 94 Six months ended Six months ended Average Interest Average Interest Commercial & Industrial Death Care Management $ 9 $ — $ — $ — Healthcare 4,721 32 3,534 48 Independent Pharmacies 1,907 33 2,784 25 Registered Investment Advisors 381 7 — — Veterinary Industry 2,675 16 3,334 8 Total 9,693 88 9,652 81 Commercial Real Estate Death Care Management 1,588 3 1,475 — Healthcare 1,055 9 2,319 — Veterinary Industry 12,319 159 12,668 90 Total 14,962 171 16,462 90 Commercial Land Agriculture 429 — — — Total 429 — — — Total $ 25,084 $ 259 $ 26,114 $ 171
Summary of Types of Troubled Debt Restructurings	The following table presents loans that were modified as TDRs within the previous twelve months ending June 30, 2016 and 2015 for which there was a payment default: June 30, 2016 June 30, 2015 TDR Defaults TDR Defaults Number of Restructurings Recorded Investment Number of Restructurings Recorded Investment Interest Only Commercial & Industrial Healthcare — $ — 3 $ 133 Independent Pharmacies — — 1 139 Commercial Real Estate Healthcare — — 1 24 Veterinary Industry — — 1 — Total Interest Only — — 6 296 Payment Deferral Commercial & Industrial Veterinary Industry 1 313 — — Commercial Real Estate Deathcare Management — — 1 1,675 Total Payment Deferral 1 313 1 1,675 Total 1 $ 313 7 $ 1,971 The following table present the types of TDRs that were made during the six months ended June 30, 2016 and 2015 : Six months ended June 30, 2016 Six months ended June 30, 2015 All Restructurings All Restructurings Number of Pre- Post- Number of Pre- Post- Interest Only Commercial & Industrial Healthcare — $ — $ — 3 $ 229 $ 133 Commercial Real Estate Healthcare — — — 1 41 24 Total Interest Only — — — 4 270 157 Payment Deferral Commercial & Industrial Veterinary Industry 1 420 420 — — — Total Payment Deferral 1 420 420 — — — Total 1 $ 420 $ 420 4 $ 270 $ 157

Servicing Assets (Tables)

Servicing Assets (Tables)	6 Months Ended
	Jun. 30, 2016
Transfers and Servicing [Abstract]
Summary of Activity Pertaining to Servicing Rights	The following summarizes the activity pertaining to servicing rights: Three Months Ended Six Months Ended 2016 2015 2016 2015 Balance at beginning of period $ 47,377 $ 38,457 $ 44,230 $ 34,999 Additions, net 3,243 3,373 6,958 6,709 Fair value changes: Due to changes in valuation inputs or assumptions (262 ) (955 ) $ 559 $ 451 Decay due to increases in principal paydowns or runoff (1,904 ) (892 ) $ (3,293 ) $ (2,176 ) Balance at end of period $ 48,454 $ 39,983 $ 48,454 $ 39,983

Borrowings (Tables)

Borrowings (Tables)	6 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
Schedule of Total Outstanding Short and Long-Term Borrowings	Total outstanding long term borrowings consisted of the following: June 30, December 31, Long term borrowings On September 11, 2014, the Company financed the construction of an additional building located on the Company’s Tiburon Drive main campus with a $24 million construction line of credit with an unaffiliated commercial bank, secured by both properties at its Tiburon Drive main facility location. Payments are interest only through September 11, 2016 at a fixed rate of 3.95% for a term of 84 months. Monthly principal and interest payments beginning in October 2016 will be $146 thousand with all principal and accrued interest due on September 11, 2021. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. The construction line is fully disbursed and there was no remaining available credit on this construction line at June 30, 2016. $ 23,995 $ 24,000 On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank, with the first advance of $5 million on December 14, 2014. The note is unsecured and accrues interest at LIBOR plus 3.50% for a term of 36 months. Payments are interest only with all principal and accrued interest due on September 18, 2017. This line of credit was paid in full on July 30, 2015 and there is $8.1 million of available credit remaining at June 30, 2016. — — On February 23, 2015, the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at June 30, 2016 is 4.50%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $4.2 million at June 30, 2016. Underlying loans carry a risk grade of 3 and are current with no delinquencies. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. 4,178 4,375 Total long term borrowings $ 28,173 $ 28,375

Fair Value of Financial Instr24

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2016
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured on a Recurring Basis	The tables below present the recorded amount of assets and liabilities measured at fair value on a recurring basis. June 30, 2016 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US government agencies $ 22,183 $ — $ 22,183 $ — Residential mortgage-backed securities 42,603 — 42,603 — Mutual fund 2,018 — 2,018 — Servicing assets 1 48,454 — — 48,454 Total assets at fair value $ 115,258 $ — $ 66,804 $ 48,454 December 31, 2015 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US government agencies $ 22,068 $ — $ 22,068 $ — Residential mortgage-backed securities 29,758 — 29,758 — Mutual fund 1,936 — 1,936 — Servicing assets 1 44,230 — — 44,230 Total assets at fair value $ 97,992 $ — $ 53,762 $ 44,230 1 See Note 6 for a rollforward of recurring Level 3 fair values for servicing assets.
Schedule of Assets and Liabilities Measured on a Nonrecurring Basis	The tables below present the recorded amount of assets and liabilities measured at fair value on a non-recurring basis. June 30, 2016 Total Level 1 Level 2 Level 3 Impaired loans $ 18,276 $ — $ — $ 18,276 Foreclosed assets 2,971 — — 2,971 Total assets at fair value $ 21,247 $ — $ — $ 21,247 December 31, 2015 Total Level 1 Level 2 Level 3 Impaired loans $ 17,084 $ — $ — $ 17,084 Foreclosed assets 2,666 — — 2,666 Total assets at fair value $ 19,750 $ — $ — $ 19,750
Schedule of Level 3 Valuation Techniques	For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of June 30, 2016 and December 31, 2015 the significant unobservable inputs used in the fair value measurements were as follows: June 30, 2016 Level 3 Assets with Significant Unobservable Inputs Fair Value Valuation Technique Significant Unobservable Inputs Range Impaired Loans $ 18,276 Discounted appraisals Appraisal adjustments (1) Interest rate & repayment term 1% to 25% Weighted average discount rate 5.49% Foreclosed Assets $ 2,971 Discounted appraisals Appraisal adjustments (1) 10% to 35% December 31, 2015 Level 3 Assets with Significant Unobservable Inputs Fair Value Valuation Technique Significant Unobservable Inputs Range Impaired Loans $ 17,084 Discounted appraisals Appraisal adjustments (1) Interest rate & repayment term 10% to 20% Weighted average discount rate 5.57% Foreclosed Assets $ 2,666 Discounted appraisals Appraisal adjustments (1) 10% to 20% (1) Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments.
Carrying Amount and Estimated Fair Value of Financial Instruments	The carrying amounts and estimated fair values of the Company’s financial instruments are as follows: June 30, 2016 Carrying Amount Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Fair Value Financial assets Cash and due from banks $ 175,506 $ 175,506 $ — $ — $ 175,506 Certificates of deposit with other banks 8,500 8,513 — — 8,513 Investment securities, available-for-sale 66,804 — 66,804 — 66,804 Loans held for sale 329,206 — — 361,520 361,520 Loans, net of allowance for loan losses 678,208 — — 672,526 672,526 Servicing assets 48,454 — — 48,454 48,454 Accrued interest receivable 6,304 6,304 — — 6,304 Financial liabilities Deposits 1,140,797 — 1,148,570 — 1,148,570 Accrued interest payable 202 202 — — 202 Long term borrowings 28,173 — — 31,044 31,044 December 31, 2015 Carrying Amount Quoted Price In Active Markets for Identical Assets /Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Fair Value Financial assets Cash and due from banks $ 102,607 $ 102,607 $ — $ — $ 102,607 Certificates of deposit with other banks 10,250 10,176 — — 10,176 Investment securities, available-for-sale 53,762 — 53,762 — 53,762 Loans held for sale 480,619 — — 497,868 497,868 Loans, net of allowance for loan losses 272,554 — — 268,816 268,816 Servicing assets 44,230 — — 44,230 44,230 Accrued interest receivable 5,556 5,556 — — 5,556 Financial liabilities Deposits 804,788 — 792,820 — 792,820 Accrued interest payable 211 211 — — 211 Long term borrowings 28,375 — — 30,523 30,523

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Schedule of Commitments	A summary of the Company’s commitments is as follows: June 30, December 31, Commitments to extend credit $ 1,185,541 $ 737,572 Standby letters of credit 343 — Plexus Capital - Fund II Investment Commitment 100 100 Plexus Capital - Fund III Investment Commitment 250 300 Five Points Mezzanine Fund III Commitment 1,464 1,500 Total unfunded off-balance sheet credit risk $ 1,187,698 $ 739,472

Stock Plans (Tables)

Stock Plans (Tables)	6 Months Ended
	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of Stock Option Activity	Stock option activity under the plan during the six month periods ended June 30, 2016 and 2015 is summarized below. Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2015 3,546,992 $ 11.17 Exercised 16,707 6.39 Forfeited 107,594 8.12 Granted 169,987 14.02 Outstanding at June 30, 2016 3,592,678 $ 11.41 8.55 years $ 13,895,411 Exercisable at June 30, 2016 333,066 $ 5.79 7.69 years $ 2,772,308 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Terms Aggregate Intrinsic Value Outstanding at December 31, 2014 1,737,570 $ 5.51 Exercised 34,930 4.40 Forfeited 66,319 4.88 Granted 636,505 11.70 Outstanding at June 30, 2015 2,272,826 $ 7.28 9.03 years $ 15,277,131 Exercisable at June 30, 2015 149,258 $ 3.76 8.20 years $ 1,528,763
Summary of Non-vested Stock Option Activity	The following is a summary of non-vested stock option activity for the Company for the six months ended June 30, 2016 and 2015 . Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2015 3,393,441 $ 4.56 Granted 169,987 6.58 Vested 196,222 1.48 Forfeited 107,594 2.54 Non-vested at June 30, 2016 3,259,612 $ 4.89 Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2014 1,704,230 $ 1.18 Granted 636,505 4.59 Vested 150,848 0.54 Forfeited 66,319 0.83 Non-vested at June 30, 2015 2,123,568 $ 2.26
Summary of Restricted Stock Activity	RSU stock activity under the plan during the first six months of 2016 is summarized below. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2015 64,271 $ 16.17 Granted 520,744 15.86 Vested 2,776 10.63 Forfeited 447 10.63 Non-vested at June 30, 2016 581,792 $ 15.92 Market RSU stock activity under the plan during the first six months of 2016 is summarized below. Shares Weighted Average Grant Date Fair Value Non-vested at December 31, 2015 — $ — Granted 850,000 7.06 Vested — — Forfeited — — Non-vested at June 30, 2016 850,000 $ 7.06

Basis of Presentation - Nature

Basis of Presentation - Nature of Operations (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Jun. 30, 2015	Feb. 02, 2015	Feb. 01, 2015
Schedule of Equity Method Investments [Line Items]
Contingent consideration in acquisition of controlling interest in equity method of investment	$ 0	$ 170
504FA
Schedule of Equity Method Investments [Line Items]
Equity ownership percentage				50.00%
Ownership percentage by parent	92.90%		91.30%
Percentage of voting interest acquired			41.30%
Contingent consideration in acquisition of controlling interest in equity method of investment			$ 170
Ownership percentage with noncontrolling owners	7.10%

Basis of Presentation - Busines

Basis of Presentation - Business Segments (Details)	6 Months Ended
	Jun. 30, 2016Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of significant operation segments	1

Basis of Presentation Basis of

Basis of Presentation Basis of Presentation - Allowance for Loan Losses (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2016	Jun. 30, 2015
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for sale reclassified to held for investment		$ 336,263	$ 7,400
Provision for loan losses due to transfer of loans from held for sale to held for investment	$ 4,000
Reduction to provision for loan losses due to revisions	390
Unguaranteed
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for sale reclassified to held for investment	$ 318,800	$ 318,800

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Basic and Diluted Earnings Per Share Computed Based on Weighted Average Number of Shares Outstanding (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Basic earnings per share:
Net income available to common shareholders	$ 123	$ 3,935	$ 4,814	$ 12,008
Weighted-average basic shares outstanding (in shares)	34,189,217	28,636,182	34,183,004	28,628,177
Basic earnings per share (in dollars per share)	$ 0	$ 0.14	$ 0.14	$ 0.42
Diluted earnings per share:
Net income available to common shareholders, for diluted earnings per share	$ 123	$ 3,935	$ 4,814	$ 12,008
Total weighted-average basic shares outstanding (in shares)	34,189,217	28,636,182	34,183,004	28,628,177
Add effect of dilutive stock options and restricted stock grants	1,016,908	862,217	896,656	811,645
Total weighted-average diluted shares outstanding (in shares)	35,206,125	29,498,399	35,079,660	29,439,822
Diluted earnings per share (in dollars per share)	$ 0	$ 0.13	$ 0.14	$ 0.41
Anti-dilutive shares (in shares)	1,807,823	916,199	1,807,823	956,199

Securities - Summary of Carryin

Securities - Summary of Carrying Amount and Fair Value of Securities (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	$ 66,477	$ 54,074
Unrealized Gains	363	82
Unrealized Losses	36	394
Fair Value	66,804	53,762	[1]
US government agencies
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	22,018	21,992
Unrealized Gains	165	81
Unrealized Losses	0	5
Fair Value	22,183	22,068
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	42,478	30,131
Unrealized Gains	161	1
Unrealized Losses	36	374
Fair Value	42,603	29,758
Mutual fund
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	1,981	1,951
Unrealized Gains	37	0
Unrealized Losses	0	15
Fair Value	$ 2,018	$ 1,936
[1]	Derived from audited consolidated financial statements.

Securities - Summary of Gross U

Securities - Summary of Gross Unrealized Losses and Fair Value (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less Than 12 Months	$ 2,401	$ 35,941
Unrealized Losses, Less Than 12 Months	16	353
Fair Value, 12 Months or More	5,494	3,019
Unrealized Losses, 12 Months or More	20	41
Total Fair Value	7,895	38,960
Total Unrealized Losses	36	394
US government agencies
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less Than 12 Months		7,990
Unrealized Losses, Less Than 12 Months		5
Fair Value, 12 Months or More		0
Unrealized Losses, 12 Months or More		0
Total Fair Value		7,990
Total Unrealized Losses		5
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less Than 12 Months	2,401	26,015
Unrealized Losses, Less Than 12 Months	16	333
Fair Value, 12 Months or More	5,494	3,019
Unrealized Losses, 12 Months or More	20	41
Total Fair Value	7,895	29,034
Total Unrealized Losses	$ 36	374
Mutual fund
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less Than 12 Months		1,936
Unrealized Losses, Less Than 12 Months		15
Fair Value, 12 Months or More		0
Unrealized Losses, 12 Months or More		0
Total Fair Value		1,936
Total Unrealized Losses		$ 15

Securities - Summary of Investm

Securities - Summary of Investment Securities by Maturity (Detail) $ in Thousands	Jun. 30, 2016USD ($)
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Rolling Maturity [Abstract]
Total, amortized cost	$ 64,496
Available-for-sale Securities, Debt Maturities, Fair Value, Rolling Maturity [Abstract]
Total, fair value	64,786
US government agencies
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Rolling Maturity [Abstract]
Within one year, amortized cost	9,210
One to five years, amortized cost	12,808
Total, amortized cost	22,018
Available-for-sale Securities, Debt Maturities, Fair Value, Rolling Maturity [Abstract]
Within one year, fair value	9,227
One to five years, fair value	12,956
Total, fair value	22,183
Residential mortgage-backed securities
Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Rolling Maturity [Abstract]
Five to ten years, amortized cost	8,324
After 10 years, amortized cost	34,154
Total, amortized cost	42,478
Available-for-sale Securities, Debt Maturities, Fair Value, Rolling Maturity [Abstract]
Five to ten years, fair value	8,402
After 10 years, fair value	34,201
Total, fair value	$ 42,603

Securities - Additional Informa

Securities - Additional Information (Detail)	3 Months Ended				6 Months Ended
	Jun. 30, 2016USD ($)Security	Mar. 31, 2016USD ($)Security	Jun. 30, 2015USD ($)Security	Mar. 31, 2015USD ($)$ / sharesshares	Jun. 30, 2016USD ($)Security	Jun. 30, 2015USD ($)Security	Dec. 31, 2015USD ($)Security
Schedule of Available-for-sale Securities [Line Items]
Purchases of securities available-for-sale					$ 14,799,000	$ 5,925,000
Number of securities called, sold, or matured | Security	0		0		0	0
Other than temporary impairment losses					$ 0
Residential mortgage-backed securities
Schedule of Available-for-sale Securities [Line Items]
Number of mortgage-backed securities purchased | Security	4	1	2
Purchases of securities available-for-sale	$ 12,300,000	$ 2,400,000	$ 4,000,000
Number of securities sold | Security			6
Proceeds from Sale of Available-for-sale Securities			$ 3,400,000
Number of securities in unrealized loss portions for longer than 12 months | Security	4				4		3
Number of securities in unrealized loss positions for less than 12 months | Security	1				1		12
504 Fund Mutual Fund
Schedule of Available-for-sale Securities [Line Items]
Purchases of securities available-for-sale				$ 1,900,000
Dividend reinvestment					$ 30,000
Number of shares acquired from investment in 504 Fund mutual fund ( in shares) | shares				190,380.762
Shares acquired from investment in 504 Fund mutual fund (in $ per share) | $ / shares				$ 9.98
US government agencies
Schedule of Available-for-sale Securities [Line Items]
Number of securities in unrealized loss positions for less than 12 months | Security							1
Correspondent Bank | Line of Credit
Schedule of Available-for-sale Securities [Line Items]
Investment securities pledged to secure line of credit	$ 1,200,000				1,200,000		$ 1,300,000
Ohio State Treasurer
Schedule of Available-for-sale Securities [Line Items]
Investment securities pledged to secure line of credit	$ 101,000				$ 101,000

Loans Held for Investment and35

Loans Held for Investment and Allowance for Loan Losses - (Summary of Loans) (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 689,491	$ 279,946
Net Deferred Costs	6,902	3,056
Discount on SBA 7(a) Unguaranteed	(5,876)	(3,033)
Loans held for investment	690,517	279,969	[1]
Commercial & Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	244,678	104,857
Commercial & Industrial | Agriculture
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	463	30
Commercial & Industrial | Death Care Management
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	9,753	4,832
Commercial & Industrial | Healthcare
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	32,959	15,240
Commercial & Industrial | Independent Pharmacies
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	77,818	41,588
Commercial & Industrial | Registered Investment Advisors
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	54,091	18,358
Commercial & Industrial | Veterinary Industry
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	37,584	21,579
Commercial & Industrial | Other Industries
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	32,010	3,230
Construction & Development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	85,852	24,322
Construction & Development | Agriculture
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	35,041	11,351
Construction & Development | Death Care Management
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	2,455	769
Construction & Development | Healthcare
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	23,561	7,231
Construction & Development | Independent Pharmacies
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	2,081	101
Construction & Development | Registered Investment Advisors
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	703	378
Construction & Development | Veterinary Industry
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	10,534	3,834
Construction & Development | Other Industries
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	11,477	658
Commercial Real Estate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	286,318	134,731
Commercial Real Estate | Agriculture
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	5,672	1,863
Commercial Real Estate | Death Care Management
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	45,162	20,327
Commercial Real Estate | Healthcare
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	95,146	37,684
Commercial Real Estate | Independent Pharmacies
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	13,650	7,298
Commercial Real Estate | Registered Investment Advisors
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	6,787	2,808
Commercial Real Estate | Veterinary Industry
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	96,162	59,999
Commercial Real Estate | Other Industries
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	23,739	4,752
Commercial Land
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	72,643	16,036
Commercial Land | Agriculture
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	72,643	16,036
Loans Insured or Guaranteed by US Government Authorities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 28,500	$ 17,200
[1]	Derived from audited consolidated financial statements.

Loans Held for Investment and36

Loans Held for Investment and Allowance for Loan Losses - (Credit Risk Profile, Narrative) (Detail)	6 Months Ended
	Jun. 30, 2016Score
Maximum | Loans (1 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loan-to-value ratio	65.00%
Maximum | Loans (2 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loan-to-value ratio	75.00%
Maximum | Loans (4 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash flow coverage	1
Minimum | Loans (1 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt service coverage	1.75
Discounted collateral coverage	125.00%
Credit score	740
Minimum | Loans (3 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt service coverage	1
Minimum | Loans (2 Rated)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt service coverage	1.25
Discounted collateral coverage	100.00%
Credit score	700

Loans Held for Investment and37

Loans Held for Investment and Allowance for Loan Losses - (Summary of Risk Grades of Each Category of Loans) (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Financing Receivable, Recorded Investment [Line Items]
Total Loans	$ 689,491	$ 279,946
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment [Line Items]
Total Loans	28,500	17,200
Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	637,740	238,979
Risk Grades 1 - 4 | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment [Line Items]
Total Loans	7,700	0
Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	29,781	17,526
Risk Grade 5 | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment [Line Items]
Total Loans	7,600	2,600
Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	21,970	23,441
Risk Grades 6 - 8 | Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment [Line Items]
Total Loans	13,200	14,600
Commercial & Industrial
Financing Receivable, Recorded Investment [Line Items]
Total Loans	244,678	104,857
Commercial & Industrial | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	225,875	87,193
Commercial & Industrial | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	10,249	8,502
Commercial & Industrial | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	8,554	9,162
Commercial & Industrial | Agriculture
Financing Receivable, Recorded Investment [Line Items]
Total Loans	463	30
Commercial & Industrial | Agriculture | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	406	30
Commercial & Industrial | Agriculture | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	57	0
Commercial & Industrial | Agriculture | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Commercial & Industrial | Death Care Management
Financing Receivable, Recorded Investment [Line Items]
Total Loans	9,753	4,832
Commercial & Industrial | Death Care Management | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	9,518	4,728
Commercial & Industrial | Death Care Management | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	226	104
Commercial & Industrial | Death Care Management | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	9	0
Commercial & Industrial | Healthcare
Financing Receivable, Recorded Investment [Line Items]
Total Loans	32,959	15,240
Commercial & Industrial | Healthcare | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	25,201	8,334
Commercial & Industrial | Healthcare | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	3,362	2,160
Commercial & Industrial | Healthcare | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	4,396	4,746
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Recorded Investment [Line Items]
Total Loans	77,818	41,588
Commercial & Industrial | Independent Pharmacies | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	72,619	36,704
Commercial & Industrial | Independent Pharmacies | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	3,620	3,430
Commercial & Industrial | Independent Pharmacies | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,579	1,454
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Recorded Investment [Line Items]
Total Loans	54,091	18,358
Commercial & Industrial | Registered Investment Advisors | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	52,617	17,508
Commercial & Industrial | Registered Investment Advisors | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,101	850
Commercial & Industrial | Registered Investment Advisors | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	373	0
Commercial & Industrial | Veterinary Industry
Financing Receivable, Recorded Investment [Line Items]
Total Loans	37,584	21,579
Commercial & Industrial | Veterinary Industry | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	33,504	16,800
Commercial & Industrial | Veterinary Industry | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,883	1,817
Commercial & Industrial | Veterinary Industry | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,197	2,962
Commercial & Industrial | Other Industries
Financing Receivable, Recorded Investment [Line Items]
Total Loans	32,010	3,230
Commercial & Industrial | Other Industries | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	32,010	3,089
Commercial & Industrial | Other Industries | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	141
Commercial & Industrial | Other Industries | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development
Financing Receivable, Recorded Investment [Line Items]
Total Loans	85,852	24,322
Construction & Development | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	82,032	22,912
Construction & Development | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	3,820	1,410
Construction & Development | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Agriculture
Financing Receivable, Recorded Investment [Line Items]
Total Loans	35,041	11,351
Construction & Development | Agriculture | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	35,041	11,194
Construction & Development | Agriculture | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	157
Construction & Development | Agriculture | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Death Care Management
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,455	769
Construction & Development | Death Care Management | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,049	769
Construction & Development | Death Care Management | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	406	0
Construction & Development | Death Care Management | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Healthcare
Financing Receivable, Recorded Investment [Line Items]
Total Loans	23,561	7,231
Construction & Development | Healthcare | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	21,340	7,231
Construction & Development | Healthcare | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,221	0
Construction & Development | Healthcare | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Independent Pharmacies
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,081	101
Construction & Development | Independent Pharmacies | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,081	101
Construction & Development | Independent Pharmacies | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Independent Pharmacies | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Registered Investment Advisors
Financing Receivable, Recorded Investment [Line Items]
Total Loans	703	378
Construction & Development | Registered Investment Advisors | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	703	378
Construction & Development | Registered Investment Advisors | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Registered Investment Advisors | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Veterinary Industry
Financing Receivable, Recorded Investment [Line Items]
Total Loans	10,534	3,834
Construction & Development | Veterinary Industry | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	9,341	2,581
Construction & Development | Veterinary Industry | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,193	1,253
Construction & Development | Veterinary Industry | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Other Industries
Financing Receivable, Recorded Investment [Line Items]
Total Loans	11,477	658
Construction & Development | Other Industries | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	11,477	658
Construction & Development | Other Industries | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Construction & Development | Other Industries | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Commercial Real Estate
Financing Receivable, Recorded Investment [Line Items]
Total Loans	286,318	134,731
Commercial Real Estate | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	259,197	112,838
Commercial Real Estate | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	13,822	7,614
Commercial Real Estate | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	13,299	14,279
Commercial Real Estate | Agriculture
Financing Receivable, Recorded Investment [Line Items]
Total Loans	5,672	1,863
Commercial Real Estate | Agriculture | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	5,672	1,863
Commercial Real Estate | Agriculture | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Commercial Real Estate | Agriculture | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Commercial Real Estate | Death Care Management
Financing Receivable, Recorded Investment [Line Items]
Total Loans	45,162	20,327
Commercial Real Estate | Death Care Management | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	41,173	18,223
Commercial Real Estate | Death Care Management | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,405	425
Commercial Real Estate | Death Care Management | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,584	1,679
Commercial Real Estate | Healthcare
Financing Receivable, Recorded Investment [Line Items]
Total Loans	95,146	37,684
Commercial Real Estate | Healthcare | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	88,389	33,529
Commercial Real Estate | Healthcare | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	5,724	2,930
Commercial Real Estate | Healthcare | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,033	1,225
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Recorded Investment [Line Items]
Total Loans	13,650	7,298
Commercial Real Estate | Independent Pharmacies | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	12,053	6,210
Commercial Real Estate | Independent Pharmacies | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,597	1,088
Commercial Real Estate | Independent Pharmacies | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Commercial Real Estate | Registered Investment Advisors
Financing Receivable, Recorded Investment [Line Items]
Total Loans	6,787	2,808
Commercial Real Estate | Registered Investment Advisors | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	6,787	2,808
Commercial Real Estate | Registered Investment Advisors | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Commercial Real Estate | Registered Investment Advisors | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Commercial Real Estate | Veterinary Industry
Financing Receivable, Recorded Investment [Line Items]
Total Loans	96,162	59,999
Commercial Real Estate | Veterinary Industry | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	81,384	45,453
Commercial Real Estate | Veterinary Industry | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	4,096	3,171
Commercial Real Estate | Veterinary Industry | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	10,682	11,375
Commercial Real Estate | Other Industries
Financing Receivable, Recorded Investment [Line Items]
Total Loans	23,739	4,752
Commercial Real Estate | Other Industries | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	23,739	4,752
Commercial Real Estate | Other Industries | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Commercial Real Estate | Other Industries | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Commercial Land
Financing Receivable, Recorded Investment [Line Items]
Total Loans	72,643	16,036
Commercial Land | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	70,636	16,036
Commercial Land | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,890	0
Commercial Land | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	117	0
Commercial Land | Agriculture
Financing Receivable, Recorded Investment [Line Items]
Total Loans	72,643	16,036
Commercial Land | Agriculture | Risk Grades 1 - 4
Financing Receivable, Recorded Investment [Line Items]
Total Loans	70,636	16,036
Commercial Land | Agriculture | Risk Grade 5
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,890	0
Commercial Land | Agriculture | Risk Grades 6 - 8
Financing Receivable, Recorded Investment [Line Items]
Total Loans	$ 117	$ 0

Loans Held for Investment and38

Loans Held for Investment and Allowance for Loan Losses - (Summary of Age Analysis of Past Due Loans) (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	$ 18,656	$ 20,832
Current Loans	670,835	259,114
Total Loans	689,491	279,946
Loans 90 Days or More Past Due & Still Accruing	0	0
Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	3,075	2,289
30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	5,754	8,465
30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	1,333	3,344
Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	8,494	6,734
Commercial & Industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	6,251	7,337
Current Loans	238,427	97,520
Total Loans	244,678	104,857
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	384	522
Commercial & Industrial | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	991	2,923
Commercial & Industrial | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	1,333	1,161
Commercial & Industrial | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	3,543	2,731
Commercial & Industrial | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	463	30
Total Loans	463	30
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial | Agriculture | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Agriculture | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Agriculture | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Agriculture | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Death Care Management
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	9,753	4,832
Total Loans	9,753	4,832
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial | Death Care Management | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Death Care Management | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Death Care Management | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Death Care Management | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	3,282	4,221
Current Loans	29,677	11,019
Total Loans	32,959	15,240
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial | Healthcare | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Healthcare | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	576	1,854
Commercial & Industrial | Healthcare | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	487	30
Commercial & Industrial | Healthcare | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	2,219	2,337
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	1,135	917
Current Loans	76,683	40,671
Total Loans	77,818	41,588
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial | Independent Pharmacies | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	294	314
Commercial & Industrial | Independent Pharmacies | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	415	603
Commercial & Industrial | Independent Pharmacies | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	156	0
Commercial & Industrial | Independent Pharmacies | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	270	0
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	54,091	18,358
Total Loans	54,091	18,358
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial | Registered Investment Advisors | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Registered Investment Advisors | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Registered Investment Advisors | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Registered Investment Advisors | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	1,834	2,199
Current Loans	35,750	19,380
Total Loans	37,584	21,579
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial | Veterinary Industry | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	90	208
Commercial & Industrial | Veterinary Industry | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	466
Commercial & Industrial | Veterinary Industry | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	690	1,131
Commercial & Industrial | Veterinary Industry | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	1,054	394
Commercial & Industrial | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	32,010	3,230
Total Loans	32,010	3,230
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial | Other Industries | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Other Industries | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Other Industries | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial & Industrial | Other Industries | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	85,852	24,322
Total Loans	85,852	24,322
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	35,041	11,351
Total Loans	35,041	11,351
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development | Agriculture | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Agriculture | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Agriculture | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Agriculture | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Death Care Management
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	2,455	769
Total Loans	2,455	769
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development | Death Care Management | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Death Care Management | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Death Care Management | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Death Care Management | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	23,561	7,231
Total Loans	23,561	7,231
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development | Healthcare | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Healthcare | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Healthcare | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Healthcare | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	2,081	101
Total Loans	2,081	101
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development | Independent Pharmacies | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Independent Pharmacies | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Independent Pharmacies | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Independent Pharmacies | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	703	378
Total Loans	703	378
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development | Registered Investment Advisors | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Registered Investment Advisors | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Registered Investment Advisors | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Registered Investment Advisors | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	10,534	3,834
Total Loans	10,534	3,834
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development | Veterinary Industry | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Veterinary Industry | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Veterinary Industry | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Veterinary Industry | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	11,477	658
Total Loans	11,477	658
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development | Other Industries | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Other Industries | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Other Industries | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Construction & Development | Other Industries | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	12,288	13,495
Current Loans	274,030	121,236
Total Loans	286,318	134,731
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Real Estate | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	2,574	1,767
Commercial Real Estate | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	4,763	5,542
Commercial Real Estate | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	2,183
Commercial Real Estate | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	4,951	4,003
Commercial Real Estate | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	5,672	1,863
Total Loans	5,672	1,863
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Real Estate | Agriculture | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Agriculture | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Agriculture | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Agriculture | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Death Care Management
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	1,644	1,679
Current Loans	43,518	18,648
Total Loans	45,162	20,327
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Real Estate | Death Care Management | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	1,456
Commercial Real Estate | Death Care Management | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	221	223
Commercial Real Estate | Death Care Management | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Death Care Management | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	1,423	0
Commercial Real Estate | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	817	1,206
Current Loans	94,329	36,478
Total Loans	95,146	37,684
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Real Estate | Healthcare | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	350	0
Commercial Real Estate | Healthcare | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	258	240
Commercial Real Estate | Healthcare | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	135
Commercial Real Estate | Healthcare | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	209	831
Commercial Real Estate | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	13,650	7,298
Total Loans	13,650	7,298
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Real Estate | Independent Pharmacies | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Independent Pharmacies | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Independent Pharmacies | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Independent Pharmacies | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Registered Investment Advisors
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	6,787	2,808
Total Loans	6,787	2,808
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Real Estate | Registered Investment Advisors | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Registered Investment Advisors | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Registered Investment Advisors | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Registered Investment Advisors | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	9,827	10,610
Current Loans	86,335	49,389
Total Loans	96,162	59,999
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Real Estate | Veterinary Industry | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	2,224	311
Commercial Real Estate | Veterinary Industry | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	4,284	5,079
Commercial Real Estate | Veterinary Industry | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	2,048
Commercial Real Estate | Veterinary Industry | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	3,319	3,172
Commercial Real Estate | Other Industries
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Current Loans	23,739	4,752
Total Loans	23,739	4,752
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Real Estate | Other Industries | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Other Industries | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Other Industries | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Real Estate | Other Industries | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Land
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	117	0
Current Loans	72,526	16,036
Total Loans	72,643	16,036
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Land | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	117	0
Commercial Land | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Land | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Land | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Land | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	117	0
Current Loans	72,526	16,036
Total Loans	72,643	16,036
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Land | Agriculture | Less Than 30 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	117	0
Commercial Land | Agriculture | 30-89 Days Past Due & Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Land | Agriculture | 30-89 Days Past Due & Not Accruing
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Commercial Land | Agriculture | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	0	0
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	17,600	4,600
Total Loans	28,500	17,200
Loans Insured or Guaranteed by US Government Authorities | Greater Than 90 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	7,400	5,900
Loans Insured or Guaranteed by US Government Authorities | Financing Receivables 30 To 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing & Past Due Loans	$ 3,500	$ 6,700

Loans Held for Investment and39

Loans Held for Investment and Allowance for Loan Losses - (Schedule of Nonaccrual Loans) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Financing Receivable, Recorded Investment, Past Due [Line Items]
Theoretical increase in interest if interest on nonaccrual loans had been accrued in accordance with original terms	$ 162	$ 102	$ 301	$ 261
Nonaccrual loans balance	12,902		12,902		$ 12,367
Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	10,728		10,728		10,330
Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	2,174		2,174		2,037
Commercial & Industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	5,260		5,260		4,414
Commercial & Industrial | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	4,709		4,709		4,068
Commercial & Industrial | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	551		551		346
Commercial & Industrial | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	2,706		2,706		2,367
Commercial & Industrial | Healthcare | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	2,463		2,463		2,188
Commercial & Industrial | Healthcare | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	243		243		179
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	720		720		314
Commercial & Industrial | Independent Pharmacies | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	558		558		308
Commercial & Industrial | Independent Pharmacies | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	162		162		6
Commercial & Industrial | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,834		1,834		1,733
Commercial & Industrial | Veterinary Industry | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,688		1,688		1,572
Commercial & Industrial | Veterinary Industry | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	146		146		161
Commercial Real Estate
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	7,525		7,525		7,953
Commercial Real Estate | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	5,902		5,902		6,262
Commercial Real Estate | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,623		1,623		1,691
Commercial Real Estate | Healthcare
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	559		559		966
Commercial Real Estate | Healthcare | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	306		306		798
Commercial Real Estate | Healthcare | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	253		253		168
Commercial Real Estate | Veterinary Industry
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	5,543		5,543		5,531
Commercial Real Estate | Veterinary Industry | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	4,332		4,332		4,174
Commercial Real Estate | Veterinary Industry | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,211		1,211		1,357
Commercial Real Estate | Death Care Management
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,423		1,423		1,456
Commercial Real Estate | Death Care Management | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,264		1,264		1,290
Commercial Real Estate | Death Care Management | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	159		159		$ 166
Commercial Land
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	117		117
Commercial Land | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	117		117
Commercial Land | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	0		0
Commercial Land | Agriculture
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	117		117
Commercial Land | Agriculture | Guaranteed Balance
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	117		117
Commercial Land | Agriculture | Unguaranteed Exposure
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	$ 0		$ 0

Loans Held for Investment and40

Loans Held for Investment and Allowance for Loan Losses - (Schedule of Allowance for Loan Losses by Portfolio Segment Allowance) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016		Jun. 30, 2015
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	$ 8,616	$ 5,234	$ 7,415	[1]	$ 4,407
Charge offs	(163)	(228)	(438)		(479)
Recoveries	403	127	446		128
Provision	3,453	50	4,886		1,127
Allowance for Loan Losses, Ending Balance	12,309	5,183	12,309		5,183
Construction & Development
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	1,163	755	1,064		586
Charge offs	0	0	0		0
Recoveries	0	0	0		0
Provision	45	89	144		258
Allowance for Loan Losses, Ending Balance	1,208	844	1,208		844
Commercial Real Estate
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	2,575	2,062	2,486		2,291
Charge offs	0	(42)	(7)		(121)
Recoveries	3	87	3		88
Provision	1,501	239	1,597		88
Allowance for Loan Losses, Ending Balance	4,079	2,346	4,079		2,346
Commercial & Industrial
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	3,345	2,063	2,766		1,369
Charge offs	(100)	(186)	(368)		(358)
Recoveries	400	40	443		40
Provision	1,956	(264)	2,760		602
Allowance for Loan Losses, Ending Balance	5,601	1,653	5,601		1,653
Commercial Land
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	1,533	354	1,099		161
Charge offs	(63)	0	(63)		0
Recoveries	0	0	0		0
Provision	(49)	(14)	385		179
Allowance for Loan Losses, Ending Balance	$ 1,421	$ 340	$ 1,421		$ 340
[1]	Derived from audited consolidated financial statements.

Loans Held for Investment and41

Loans Held for Investment and Allowance for Loan Losses - (Schedule of Recorded Allowance for Loan Loans Receivable) (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015		Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014
Allowance for Loan Losses:
Allowance for Loan Losses, Individually evaluated for impairment	$ 1,870		$ 1,762
Allowance for Loan Losses, Collectively evaluated for impairment	10,439		5,653
Total allowance for loan losses	12,309	$ 8,616	7,415	[1]	$ 5,183	$ 5,234	$ 4,407
Loans Receivable :
Loans Receivable, Individually evaluated for impairment	14,856		13,047
Loans Receivable, Collectively evaluated for impairment	674,635		266,899
Total Loans	689,491		279,946
Loans collectively evaluated for Impairment, unguaranteed credit exposure Less Than $100,000	9,300		8,600
Loans collectively evaluated for impairment, unguaranteed credit exposure less than $100,000, allowance	589		352
Construction & Development
Allowance for Loan Losses:
Allowance for Loan Losses, Individually evaluated for impairment	0		0
Allowance for Loan Losses, Collectively evaluated for impairment	1,208		1,064
Total allowance for loan losses	1,208	1,163	1,064		844	755	586
Loans Receivable :
Loans Receivable, Individually evaluated for impairment	0		0
Loans Receivable, Collectively evaluated for impairment	85,852		24,322
Total Loans	85,852		24,322
Commercial Real Estate
Allowance for Loan Losses:
Allowance for Loan Losses, Individually evaluated for impairment	874		1,090
Allowance for Loan Losses, Collectively evaluated for impairment	3,205		1,396
Total allowance for loan losses	4,079	2,575	2,486		2,346	2,062	2,291
Loans Receivable :
Loans Receivable, Individually evaluated for impairment	11,536		9,821
Loans Receivable, Collectively evaluated for impairment	274,782		124,910
Total Loans	286,318		134,731
Commercial & Industrial
Allowance for Loan Losses:
Allowance for Loan Losses, Individually evaluated for impairment	996		672
Allowance for Loan Losses, Collectively evaluated for impairment	4,605		2,094
Total allowance for loan losses	5,601	3,345	2,766		1,653	2,063	1,369
Loans Receivable :
Loans Receivable, Individually evaluated for impairment	3,320		3,226
Loans Receivable, Collectively evaluated for impairment	241,358		101,631
Total Loans	244,678		104,857
Commercial Land
Allowance for Loan Losses:
Allowance for Loan Losses, Individually evaluated for impairment	0		0
Allowance for Loan Losses, Collectively evaluated for impairment	1,421		1,099
Total allowance for loan losses	1,421	$ 1,533	1,099		$ 340	$ 354	$ 161
Loans Receivable :
Loans Receivable, Individually evaluated for impairment	0		0
Loans Receivable, Collectively evaluated for impairment	72,643		16,036
Total Loans	72,643		16,036
Loans Insured or Guaranteed by US Government Authorities
Loans Receivable :
Loans Receivable, Individually evaluated for impairment	13,300		14,100
Total Loans	28,500		17,200
Loans collectively evaluated for Impairment, unguaranteed credit exposure Less Than $100,000	7,400		7,500
Unguaranteed Exposure
Loans Receivable :
Loans collectively evaluated for Impairment, unguaranteed credit exposure Less Than $100,000	$ 1,900		$ 1,100
[1]	Derived from audited consolidated financial statements.

Loans Held for Investment and42

Loans Held for Investment and Allowance for Loan Losses - (Summary of Impaired Loans) (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Financing Receivable, Impaired [Line Items]
Impaired loans	$ 24,122	$ 21,666
Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Impaired loans	9,261	8,244
Commercial & Industrial | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	9
Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	4,405	4,442
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	1,918	1,546
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Impaired loans	376
Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	2,553	2,256
Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Impaired loans	14,744	13,422
Commercial Real Estate | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	1,582	1,454
Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	1,032	965
Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	12,130	11,003
Commercial Land
Financing Receivable, Impaired [Line Items]
Impaired loans	117
Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans	117
Loans Insured or Guaranteed by US Government Authorities
Financing Receivable, Impaired [Line Items]
Impaired loans	13,329	14,147
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Impaired loans	5,162	5,709
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	0
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	2,463	3,341
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	870	637
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Impaired loans	0
Loans Insured or Guaranteed by US Government Authorities | Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	1,829	1,731
Loans Insured or Guaranteed by US Government Authorities | Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Impaired loans	8,050	8,438
Loans Insured or Guaranteed by US Government Authorities | Commercial Real Estate | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	1,264	1,290
Loans Insured or Guaranteed by US Government Authorities | Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	306	799
Loans Insured or Guaranteed by US Government Authorities | Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	6,480	6,349
Loans Insured or Guaranteed by US Government Authorities | Commercial Land
Financing Receivable, Impaired [Line Items]
Impaired loans	117
Loans Insured or Guaranteed by US Government Authorities | Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans	117
Unguaranteed Exposure
Financing Receivable, Impaired [Line Items]
Impaired loans	10,793	7,519
Unguaranteed Exposure | Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Impaired loans	4,099	2,535
Unguaranteed Exposure | Commercial & Industrial | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	9
Unguaranteed Exposure | Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	1,942	1,101
Unguaranteed Exposure | Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Impaired loans	1,048	909
Unguaranteed Exposure | Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Impaired loans	376
Unguaranteed Exposure | Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	724	525
Unguaranteed Exposure | Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Impaired loans	6,694	4,984
Unguaranteed Exposure | Commercial Real Estate | Death Care Management
Financing Receivable, Impaired [Line Items]
Impaired loans	318	164
Unguaranteed Exposure | Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Impaired loans	726	166
Unguaranteed Exposure | Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Impaired loans	5,650	$ 4,654
Unguaranteed Exposure | Commercial Land
Financing Receivable, Impaired [Line Items]
Impaired loans	0
Unguaranteed Exposure | Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Impaired loans	$ 0

Loans Held for Investment and43

Loans Held for Investment and Allowance for Loan Losses - (Summary of Impaired Loans Recorded Investment, Unpaid Principal Balance and Related Allowance) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	$ 20,735		$ 20,735		$ 19,176
Recorded Investment, With No Recorded Allowance	3,387		3,387		2,490
Recorded Investment, Total	24,122		24,122		21,666
Loans, Unpaid Principal Balance	25,606		25,606		24,596
Loans, Related Allowance Recorded	2,459		2,459		2,114
Loans, Average Balance	24,547	$ 27,385	25,084	$ 26,114
Loans, Interest Income Recognized	145	94	259	171
Commercial & Industrial
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	8,814		8,814		7,492
Recorded Investment, With No Recorded Allowance	447		447		752
Recorded Investment, Total	9,261		9,261		8,244
Loans, Unpaid Principal Balance	9,789		9,789		10,053
Loans, Related Allowance Recorded	1,341		1,341		903
Loans, Average Balance	9,403	9,935	9,693	9,652
Loans, Interest Income Recognized	52	43	88	81
Commercial & Industrial | Death Care Management
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	9		9
Recorded Investment, With No Recorded Allowance	0		0
Recorded Investment, Total	9		9
Loans, Unpaid Principal Balance	9		9
Loans, Related Allowance Recorded	3		3
Loans, Average Balance	9	0	9	0
Loans, Interest Income Recognized	0	0	0	0
Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	4,139		4,139		4,242
Recorded Investment, With No Recorded Allowance	266		266		200
Recorded Investment, Total	4,405		4,405		4,442
Loans, Unpaid Principal Balance	4,461		4,461		4,742
Loans, Related Allowance Recorded	671		671		478
Loans, Average Balance	4,440	3,320	4,721	3,534
Loans, Interest Income Recognized	21	25	32	48
Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	1,737		1,737		1,199
Recorded Investment, With No Recorded Allowance	181		181		347
Recorded Investment, Total	1,918		1,918		1,546
Loans, Unpaid Principal Balance	2,012		2,012		2,041
Loans, Related Allowance Recorded	338		338		287
Loans, Average Balance	1,935	3,751	1,907	2,784
Loans, Interest Income Recognized	17	13	33	25
Commercial & Industrial | Registered Investment Advisors
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	376		376
Recorded Investment, With No Recorded Allowance	0		0
Recorded Investment, Total	376		376
Loans, Unpaid Principal Balance	373		373
Loans, Related Allowance Recorded	44		44
Loans, Average Balance	379	0	381	0
Loans, Interest Income Recognized	5	0	7	0
Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,553		2,553		2,051
Recorded Investment, With No Recorded Allowance	0		0		205
Recorded Investment, Total	2,553		2,553		2,256
Loans, Unpaid Principal Balance	2,934		2,934		3,270
Loans, Related Allowance Recorded	285		285		138
Loans, Average Balance	2,640	2,864	2,675	3,334
Loans, Interest Income Recognized	9	5	16	8
Commercial Real Estate
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	11,804		11,804		11,684
Recorded Investment, With No Recorded Allowance	2,940		2,940		1,738
Recorded Investment, Total	14,744		14,744		13,422
Loans, Unpaid Principal Balance	15,637		15,637		14,543
Loans, Related Allowance Recorded	1,117		1,117		1,211
Loans, Average Balance	14,809	17,450	14,962	16,462
Loans, Interest Income Recognized	93	51	171	90
Commercial Real Estate | Death Care Management
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	1,582		1,582		1,454
Recorded Investment, With No Recorded Allowance	0		0		0
Recorded Investment, Total	1,582		1,582		1,454
Loans, Unpaid Principal Balance	1,718		1,718		1,591
Loans, Related Allowance Recorded	54		54		9
Loans, Average Balance	1,582	1,418	1,588	1,475
Loans, Interest Income Recognized	2	0	3	0
Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	903		903		965
Recorded Investment, With No Recorded Allowance	129		129		0
Recorded Investment, Total	1,032		1,032		965
Loans, Unpaid Principal Balance	1,033		1,033		1,096
Loans, Related Allowance Recorded	142		142		96
Loans, Average Balance	1,038	2,502	1,055	2,319
Loans, Interest Income Recognized	7	0	9	0
Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	9,319		9,319		9,265
Recorded Investment, With No Recorded Allowance	2,811		2,811		1,738
Recorded Investment, Total	12,130		12,130		11,003
Loans, Unpaid Principal Balance	12,886		12,886		11,856
Loans, Related Allowance Recorded	921		921		$ 1,106
Loans, Average Balance	12,189	13,530	12,319	12,668
Loans, Interest Income Recognized	84	51	159	90
Commercial Land
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	117		117
Recorded Investment, With No Recorded Allowance	0		0
Recorded Investment, Total	117		117
Loans, Unpaid Principal Balance	180		180
Loans, Related Allowance Recorded	1		1
Loans, Average Balance	335	0	429	0
Loans, Interest Income Recognized	0	0	0	0
Commercial Land | Agriculture
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	117		117
Recorded Investment, With No Recorded Allowance	0		0
Recorded Investment, Total	117		117
Loans, Unpaid Principal Balance	180		180
Loans, Related Allowance Recorded	1		1
Loans, Average Balance	335	0	429	0
Loans, Interest Income Recognized	$ 0	$ 0	$ 0	$ 0

Loans Held for Investment and44

Loans Held for Investment and Allowance for Loan Losses - (Summary of Recorded Investment in TDR Loans) (Detail) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016SecurityLoan	Jun. 30, 2015SecurityLoan	Jun. 30, 2016USD ($)SecurityLoan	Jun. 30, 2015USD ($)SecurityLoan
Financing Receivable, Modifications [Line Items]
Number of Loans | SecurityLoan	0	0	1	4
Pre- modification Recorded Investment			$ 420	$ 270
Post- modification Recorded Investment			$ 420	$ 157
Interest Only
Financing Receivable, Modifications [Line Items]
Number of Loans | SecurityLoan			0	4
Pre- modification Recorded Investment			$ 0	$ 270
Post- modification Recorded Investment			$ 0	$ 157
Interest Only | Commercial & Industrial | Healthcare
Financing Receivable, Modifications [Line Items]
Number of Loans | SecurityLoan			0	3
Pre- modification Recorded Investment			$ 0	$ 229
Post- modification Recorded Investment			$ 0	$ 133
Interest Only | Commercial Real Estate | Healthcare
Financing Receivable, Modifications [Line Items]
Number of Loans | SecurityLoan			0	1
Pre- modification Recorded Investment			$ 0	$ 41
Post- modification Recorded Investment			$ 0	$ 24
Payment Deferral
Financing Receivable, Modifications [Line Items]
Number of Loans | SecurityLoan			1	0
Pre- modification Recorded Investment			$ 420	$ 0
Post- modification Recorded Investment			$ 420	$ 0
Payment Deferral | Commercial & Industrial | Veterinary Industry
Financing Receivable, Modifications [Line Items]
Number of Loans | SecurityLoan			1	0
Pre- modification Recorded Investment			$ 420	$ 0
Post- modification Recorded Investment			$ 420	$ 0

Loans Held for Investment and45

Loans Held for Investment and Allowance for Loan Losses - (Summary of Loans that are Modified as TDRs for which there was a Payment Default) (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2016USD ($)SecurityLoan	Jun. 30, 2015USD ($)SecurityLoan
Financing Receivable, Impaired [Line Items]
Number of Restructurings | SecurityLoan	1	7
Recorded Investment | $	$ 313	$ 1,971
Interest Only
Financing Receivable, Impaired [Line Items]
Number of Restructurings | SecurityLoan	0	6
Recorded Investment | $	$ 0	$ 296
Interest Only | Commercial & Industrial | Healthcare
Financing Receivable, Impaired [Line Items]
Number of Restructurings | SecurityLoan	0	3
Recorded Investment | $	$ 0	$ 133
Interest Only | Commercial & Industrial | Independent Pharmacies
Financing Receivable, Impaired [Line Items]
Number of Restructurings | SecurityLoan	0	1
Recorded Investment | $	$ 0	$ 139
Interest Only | Commercial Real Estate | Healthcare
Financing Receivable, Impaired [Line Items]
Number of Restructurings | SecurityLoan	0	1
Recorded Investment | $	$ 0	$ 24
Interest Only | Commercial Real Estate | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Number of Restructurings | SecurityLoan	0	1
Recorded Investment | $	$ 0	$ 0
Payment Deferral
Financing Receivable, Impaired [Line Items]
Number of Restructurings | SecurityLoan	1	1
Recorded Investment | $	$ 313	$ 1,675
Payment Deferral | Commercial & Industrial | Veterinary Industry
Financing Receivable, Impaired [Line Items]
Number of Restructurings | SecurityLoan	1	0
Recorded Investment | $	$ 313	$ 0
Payment Deferral | Commercial Real Estate | Death Care Management
Financing Receivable, Impaired [Line Items]
Number of Restructurings | SecurityLoan	0	1
Recorded Investment | $	$ 0	$ 1,675

Servicing Assets - Additional I

Servicing Assets - Additional Information (Detail) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Servicing Assets at Fair Value [Line Items]
Unpaid principal balances of loan serviced for others	$ 2,120		$ 1,940
Minimum
Servicing Assets at Fair Value [Line Items]
Fair value of servicing rights, discount rates	7.60%	7.10%
Fair value of servicing rights, prepayment rates	3.40%	4.20%
Maximum
Servicing Assets at Fair Value [Line Items]
Fair value of servicing rights, discount rates	13.10%	12.40%
Fair value of servicing rights, prepayment rates	10.10%	9.60%

Servicing Assets - Summary of A

Servicing Assets - Summary of Activity Pertaining to Servicing Rights (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016		Jun. 30, 2015
Servicing Asset at Fair Value, Amount [Roll Forward]
Balance at beginning of period	$ 47,377	$ 38,457	$ 44,230	[1]	$ 34,999
Additions, net	3,243	3,373	6,958		6,709
Fair value changes due to changes in valuation inputs or assumptions	(262)	(955)	559		451
Fair value changes, decay due to increases in principal paydowns or runoffs	(1,904)	(892)	(3,293)		(2,176)
Balance at end of period	$ 48,454	$ 39,983	$ 48,454		$ 39,983
[1]	Derived from audited consolidated financial statements.

Borrowings - Schedule of Total

Borrowings - Schedule of Total Outstanding Long-Term Borrowings (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Long term borrowings
Long term borrowings	$ 28,173	$ 28,375	[1]
Line of Credit | Construction Line of Credit for Main Campus Construction
Long term borrowings
Long term borrowings	23,995	24,000
Line of Credit | Note Payable Revolving Line of Credit with Unaffiliated Commercial Bank
Long term borrowings
Long term borrowings	0	0
Notes Payable to Banks | Related Party Loans Transfered to Unaffiliated Commercial Bank
Long term borrowings
Long term borrowings	$ 4,178	$ 4,375
[1]	Derived from audited consolidated financial statements.

Borrowings - Schedule of Tota49

Borrowings - Schedule of Total Outstanding Long-Term Borrowings (Additional Information) (Detail)	Feb. 23, 2015USD ($)SecurityLoan	Sep. 18, 2014USD ($)	Sep. 11, 2014USD ($)	Jun. 30, 2016USD ($)	Dec. 14, 2014USD ($)
Construction Line of Credit for Main Campus Construction | Line of Credit
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity			$ 24,000,000
Debt instrument, fixed interest rate			3.95%
Debt instrument term			84 months
Line of credit facility, periodic payment			$ 146,000
Remaining available credit facility				$ 0
Note Payable Revolving Line of Credit with Unaffiliated Commercial Bank | Revolving Credit Facility [Member] | Line of Credit
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity		$ 8,100,000
Debt instrument term		36 months
Remaining available credit facility				$ 8,100,000
Line of credit					$ 5,000,000
Note Payable Revolving Line of Credit with Unaffiliated Commercial Bank | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) | Line of Credit
Debt Instrument [Line Items]
Basis spread on variable rate		3.50%
Related Party Loans Transfered to Unaffiliated Commercial Bank | Notes Payable to Banks
Debt Instrument [Line Items]
Debt instrument term	60 months
Number of related party loans transferred | SecurityLoan	2
Debt instrument, face amount	$ 4,700,000
Debt instrument, interest rate effective percentage				4.50%
Collateral amount				$ 4,200,000
Related Party Loans Transfered to Unaffiliated Commercial Bank | Prime Rate | Notes Payable to Banks
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%

Borrowings - (Narrative) (Detai

Borrowings - (Narrative) (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Federal funds outstanding amount	$ 0	$ 0
Repurchased agreements, borrowing capacity	5,000,000	5,000,000
Repurchases agreements, outstanding balance	0	0
Federal Funds Purchased
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity	26,500,000	26,500,000
Federal Reserve Bank Advances | Federal Reserve Bank
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity	111,500,000	86,700,000
Collateral amount	228,800,000	192,200,000
Federal Reserve Bank's discount window, outstanding balance	$ 0	$ 0

Fair Value of Financial Instr51

Fair Value of Financial Instruments - (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015		Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	$ 48,454	$ 47,377	$ 44,230	[1]	$ 39,983	$ 38,457	$ 34,999
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	48,454		44,230
Total assets at fair value	115,258		97,992
Recurring | US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	22,183		22,068
Recurring | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	42,603		29,758
Recurring | Mutual Fund
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	2,018		1,936
Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	0		0
Total assets at fair value	0		0
Recurring | Level 1 | US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | Level 1 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | Level 1 | Mutual Fund
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	0		0
Total assets at fair value	66,804		53,762
Recurring | Level 2 | US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	22,183		22,068
Recurring | Level 2 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	42,603		29,758
Recurring | Level 2 | Mutual Fund
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	2,018		1,936
Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	48,454		44,230
Total assets at fair value	48,454		44,230
Recurring | Level 3 | US government agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | Level 3 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	0		0
Recurring | Level 3 | Mutual Fund
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	$ 0		$ 0
[1]	Derived from audited consolidated financial statements.

Fair Value of Financial Instr52

Fair Value of Financial Instruments - (Assets and Liabilities Measured at Fair Value on Non-recurring Basis) (Detail) - Non-recurring Fair Value - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	$ 18,276	$ 17,084
Foreclosed assets	2,971	2,666
Total assets at fair value	21,247	19,750
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	0	0
Foreclosed assets	0	0
Total assets at fair value	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	0	0
Foreclosed assets	0	0
Total assets at fair value	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	18,276	17,084
Foreclosed assets	2,971	2,666
Total assets at fair value	$ 21,247	$ 19,750

Fair Value of Financial Instr53

Fair Value of Financial Instruments - (Level 3 Valuation Techniques) (Detail) - Level 3 - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Impaired Loans
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	$ 18,276	$ 17,084
Foreclosed Assets
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	$ 2,971	$ 2,666
Discounted appraisals Discounted expected cash flows | Impaired Loans | Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	1.00%	10.00%
Discounted appraisals Discounted expected cash flows | Impaired Loans | Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	25.00%	20.00%
Discounted appraisals Discounted expected cash flows | Foreclosed Assets | Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	10.00%	10.00%
Discounted appraisals Discounted expected cash flows | Foreclosed Assets | Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	35.00%	20.00%
Discounted appraisals | Impaired Loans | Weighted Average
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	5.49%	5.57%

Fair Value of Financial Instr54

Fair Value of Financial Instruments - (Carrying Amount and Estimated Fair Value of Financial Instruments) (Detail) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2016	Jun. 30, 2015	Mar. 31, 2016	Dec. 31, 2015		Mar. 31, 2015	Dec. 31, 2014
Financial assets
Investment securities, available-for-sale	$ 66,804	$ 66,804			$ 53,762	[1]
Servicing assets	48,454	48,454	$ 39,983	$ 47,377	44,230	[1]	$ 38,457	$ 34,999
Financial liabilities
Transfer of loans held for sale to loans held for investment		336,263	$ 7,400
Carrying Amount
Financial assets
Cash and due from banks	175,506	175,506			102,607
Certificates of deposit with other banks	8,500	8,500			10,250
Investment securities, available-for-sale	66,804	66,804			53,762
Loans held for sale	329,206	329,206			480,619
Loans, net of allowance for loan losses	678,208	678,208			272,554
Servicing assets	48,454	48,454			44,230
Accrued interest receivable	6,304	6,304			5,556
Financial liabilities
Deposits	1,140,797	1,140,797			804,788
Accrued interest payable	202	202			211
Long term borrowings	28,173	28,173			28,375
Total Fair Value
Financial assets
Cash and due from banks	175,506	175,506			102,607
Certificates of deposit with other banks	8,513	8,513			10,176
Investment securities, available-for-sale	66,804	66,804			53,762
Loans held for sale	361,520	361,520			497,868
Loans, net of allowance for loan losses	672,526	672,526			268,816
Servicing assets	48,454	48,454			44,230
Accrued interest receivable	6,304	6,304			5,556
Financial liabilities
Deposits	1,148,570	1,148,570			792,820
Accrued interest payable	202	202			211
Long term borrowings	31,044	31,044			30,523
Total Fair Value | Level 1
Financial assets
Cash and due from banks	175,506	175,506			102,607
Certificates of deposit with other banks	8,513	8,513			10,176
Investment securities, available-for-sale	0	0			0
Loans held for sale	0	0			0
Loans, net of allowance for loan losses	0	0			0
Servicing assets	0	0			0
Accrued interest receivable	6,304	6,304			5,556
Financial liabilities
Deposits	0	0			0
Accrued interest payable	202	202			211
Long term borrowings	0	0			0
Total Fair Value | Level 2
Financial assets
Cash and due from banks	0	0			0
Certificates of deposit with other banks	0	0			0
Investment securities, available-for-sale	66,804	66,804			53,762
Loans held for sale	0	0			0
Loans, net of allowance for loan losses	0	0			0
Servicing assets	0	0			0
Accrued interest receivable	0	0			0
Financial liabilities
Deposits	1,148,570	1,148,570			792,820
Accrued interest payable	0	0			0
Long term borrowings	0	0			0
Total Fair Value | Level 3
Financial assets
Cash and due from banks	0	0			0
Certificates of deposit with other banks	0	0			0
Investment securities, available-for-sale	0	0			0
Loans held for sale	361,520	361,520			497,868
Loans, net of allowance for loan losses	672,526	672,526			268,816
Servicing assets	48,454	48,454			44,230
Accrued interest receivable	0	0			0
Financial liabilities
Deposits	0	0			0
Accrued interest payable	0	0			0
Long term borrowings	31,044	31,044			$ 30,523
Unguaranteed
Financial liabilities
Transfer of loans held for sale to loans held for investment	$ 318,800	$ 318,800
[1]	Derived from audited consolidated financial statements.

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Commitments (Detail) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	$ 1,187,698	$ 739,472
Commitments to extend credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	1,185,541	737,572
Standby Letters of Credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	343	0
Plexus Capital - Fund II Investment Commitment | Short-term Debt
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	100	100
Plexus Capital - Fund III Investment Commitment | Short-term Debt
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	250	300
Five Points Mezzanine Fund III Commitment | Short-term Debt
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	$ 1,464	$ 1,500

Commitments and Contingencies56

Commitments and Contingencies - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2016USD ($)Customer
Concentration Risk [Line Items]
Commitment letters expiration period	90 days
Maximum retained credit exposure	$ 2,000,000
Seven Borrowers
Concentration Risk [Line Items]
Number of relationships that have retained unguaranteed exposure | Customer	7
Retained credit exposure	$ 21,000,000

Stock Plans - (Additional Infor

Stock Plans - (Additional Information) (Detail) - USD ($) $ in Thousands	May 24, 2016	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense		$ 581	$ 177	$ 1,173	$ 295
Intrinsic value of options exercised				$ 144	$ 218
Risk free interest rate				1.56%
Expected dividend yield				0.05%
Expected volatility				44.20%
Expected average life				7 years
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, stock options		$ 13,900		$ 13,900
Unrecognized compensation costs period recognized				3 years 7 months 6 days
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs period recognized				9 months 9 days
2015 Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common voting shares authorized	7,000,000
Options or restricted shares of expiration period	10 years
Percentage of fair market value of common stock	100.00%
Option vesting period	3 years

Stock Plans - (Summary of Stock

Stock Plans - (Summary of Stock Option Activity) (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock option based compensation expense	$ 581,000	$ 177,000	$ 1,173,000	$ 295,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Shares, outstanding, beginning balance (in shares)			3,546,992	1,737,570
Shares, exercised (in shares)			16,707	34,930
Shares, forfeited (in shares)			107,594	66,319
Shares, granted (in shares)			169,987	636,505
Shares, outstanding, ending balance (in shares)	3,592,678	2,272,826	3,592,678	2,272,826
Shares, exercisable (in shares)	333,066	149,258	333,066	149,258
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price, outstanding, beginning balance (in dollars per share)			$ 11.17	$ 5.51
Weighted average exercise price, exercised (in dollars per share)			6.39	4.40
Weighted average exercise price, forfeited (in dollars per share)			8.12	4.88
Weighted average exercise price, granted (in dollars per share)			14.02	11.70
Weighted average exercise price, outstanding, ending balance (in dollars per share)	$ 11.41	$ 7.28	11.41	7.28
Weighted average exercise price, exercisable (in dollars per share)	$ 5.79	$ 3.76	$ 5.79	$ 3.76
Weighted average remaining contractual term, outstanding			8 years 6 months 18 days	9 years 11 days
Weighted average remaining contractual term, exercisable			7 years 8 months 9 days	8 years 2 months 12 days
Aggregate intrinsic value, outstanding	$ 13,895,411	$ 15,277,131	$ 13,895,411	$ 15,277,131
Aggregate intrinsic value, exercisable	$ 2,772,308	$ 1,528,763	$ 2,772,308	$ 1,528,763

Stock Plans - (Summary of Non-v

Stock Plans - (Summary of Non-vested Stock Option Activity) (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Shares, non-vested, beginning balance (in shares)	3,393,441	1,704,230
Shares, granted (in shares)	169,987	636,505
Shares, vested (in shares)	196,222	150,848
Shares, forfeited (in shares)	107,594	66,319
Shares, non-vested, ending balance (in shares)	3,259,612	2,123,568
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted average grant date fair value, non-vested, beginning balance (in dollars per share)	$ 4.56	$ 1.18
Weighted average grant date fair value, granted (in dollars per share)	6.58	4.59
Weighted average grant date fair value, vested (in dollars per share)	1.48	0.54
Weighted average grant date fair value, forfeited (in dollars per share)	2.54	0.83
Weighted average grant date fair value, non-vested, ending balance (in dollars per share)	$ 4.89	$ 2.26

Stock Plans - (Summary of Restr

Stock Plans - (Summary of Restricted Stock Activity) (Detail) - USD ($) $ / shares in Units, $ in Thousands	May 24, 2016	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Implied term used in Monte Carlo Simulation				7 years
Risk free interest rate used in Monte Carlo Simulation				1.56%
Expected volatility used in Monte Carlo Simulation				44.20%
Expected dividend yield used in Monte Carlo Simulation				0.05%
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Shares, outstanding, beginning balance (in shares)				64,271
Granted (in shares)				520,744
Vested (in shares)				2,776
Forfeited (in shares)				447
Shares, outstanding, ending balance (in shares)		581,792		581,792
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Shares outstanding, weighted average grant date fair value, beginning balance (in dollars per share)				$ 16.17
Shares granted, weighted average grant date fair value (in dollars per share)				15.86
Shares vested, weighted average grant date fair value (in dollars per share)				10.63
Shares forfeited, weighted average grant date fair value (in dollars per share)				10.63
Shares outstanding, weighted average grant date fair value, ending balance (in dollars per share)		$ 15.92		$ 15.92
Share-based compensation expense		$ 2,100	$ 8	$ 2,200	$ 16
Unrecognized compensation costs		$ 7,000		$ 7,000
Unrecognized compensation costs period recognized				9 months 9 days
Market Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Shares, outstanding, beginning balance (in shares)				0
Granted (in shares)				850,000
Vested (in shares)				0
Forfeited (in shares)				0
Shares, outstanding, ending balance (in shares)		850,000		850,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Shares outstanding, weighted average grant date fair value, beginning balance (in dollars per share)				$ 0
Shares granted, weighted average grant date fair value (in dollars per share)				7.06
Shares vested, weighted average grant date fair value (in dollars per share)				0
Shares forfeited, weighted average grant date fair value (in dollars per share)				0
Shares outstanding, weighted average grant date fair value, ending balance (in dollars per share)		$ 7.06		$ 7.06
Minimum required consecutive trading days that common stock must close at or above required share price	20 days
Minimum required closing share price	$ 34
Share-based compensation expense		$ 231		$ 231
Unrecognized compensation costs		$ 5,800		$ 5,800
Unrecognized compensation costs period recognized				4 years 2 months 1 day
Period used in Cox, Ross & Rubinstein pricing model				6 years 9 months 29 days
Implied term used in Monte Carlo Simulation				4 years 2 months 12 days
Risk free interest rate used in Monte Carlo Simulation				1.68%
Expected volatility used in Monte Carlo Simulation				30.00%
Expected dividend yield used in Monte Carlo Simulation				0.25%